Amlodipine Besylate

• Recruiting NCT NCT02904291

  Bariatric Surgery and Pharmacokinetics of Amlodipine

  Norwegian University of Science and Technology 12 participants Est. completion 2026-05 1 site
  Other conditions: Obesity, Morbid
  View official trial listing →
• Recruiting NCT NCT03264352

  Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes

  Not yet reported XueQing Yu 11414 participants Est. completion 2029-09-01 1 site
  Type 2 diabetes Other conditions: Adverse Event, Blood Pressure, Prehypertension, Cardiovascular Risk Factor
  View official trial listing →
• Recruiting NCT NCT04191681

  Safety and Efficacy of ARNI After LVAD ImplanT (SEAL-IT) Study

  Not yet reported The Cleveland Clinic 50 participants Est. completion 2022-12 1 site Stand-alone
  Heart failure
  View official trial listing →
• Recruiting NCT NCT04974138

  China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-CC/CT)

  Not yet reported Shenzhen Ausa Pharmed Co.,Ltd 32000 participants Est. completion 2030-06-30 20 sites Stand-alone
  Other conditions: Hypertension, MTHFR 677 CC or CT Genotype, Elevated Plasma Homocysteine (Hcy≥10µmol/L), Insufficient Plasma Folate Levels (<12ng/mL)
  View official trial listing →
• Recruiting NCT NCT04974151

  China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT Genotype

  Not yet reported Shenzhen Ausa Pharmed Co.,Ltd 24000 participants Est. completion 2029-06-30 20 sites Stand-alone
  Other conditions: Hypertension, MTHFR 677 TT Genotype
  View official trial listing →
• Recruiting NCT NCT05293756

  OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)

  Not yet reported Case Western Reserve University 208 participants Est. completion 2027-05-31 1 site Stand-alone
  Other conditions: Hypertension, Self-Management, Technology, Quality of Life
  View official trial listing →
• Recruiting NCT NCT05312892

  Sympathetic Mechanisms in Obesity-Crossover Design

  Not yet reported, Not yet reported Vanderbilt University Medical Center 12 participants Est. completion 2030-12-31 1 site
  Other conditions: Obesity, Hypertension
  View official trial listing →
• Recruiting NCT NCT06150560

  A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)

  Not yet reported Mayo Clinic 120 participants Est. completion 2028-06-01 1 site
  Other conditions: Coarctation of Aorta, High Blood Pressure
  View official trial listing →
• Recruiting NCT NCT06424834

  Efficacy of Targeted Medical Therapy in Angina and Nonobstructive Coronary Arteries

  Not yet reported, Not yet reported Stanford University 150 participants Est. completion 2026-12 1 site Stand-alone
  Other conditions: Angina Pectoris, Microvascular Angina, Vasospastic Angina, Myocardial Bridge of Coronary Artery
  View official trial listing →
• Recruiting NCT NCT06523465

  Statin Combined with Amlodipine Treats Primary Aldosteronism

  Not yet reported Third Military Medical University 180 participants Est. completion 2026-09-30 1 site Stand-alone
  Other conditions: Primary Aldosteronism, Statin, Mineralocorticoid Receptor Antagonist, Hypertension
  View official trial listing →
• Recruiting NCT NCT06625346

  Clinical Response of EXTOR (Amlodipine/Valsartan) in Newly Diagnosed Hypertensive Patients.

  The Searle Company Limited Pakistan 420 participants Est. completion 2025-09-15 2 sites
  Other conditions: Hypertension
  View official trial listing →
• Recruiting NCT NCT06826872

  Efficacy and Safety of SPC1001 in Patients With Essential Hypertension

  Not yet reported Shin Poong Pharmaceutical Co. Ltd. 252 participants Est. completion 2025-12-30 1 site
  Cardiovascular disease Other conditions: Hypertension, Essential, Cardiology
  View official trial listing →
• Recruiting NCT NCT07099677

  Short-Term Effects of Antihypertensive Drugs on Postural Balance and Fall Risk

  Not yet reported Abant Izzet Baysal University 186 participants Est. completion 2026-06-30 1 site Stand-alone
  Other conditions: Hypertension, Fall Risk, Postural Balance, Fear of Falling
  View official trial listing →
• Recruiting NCT NCT07458880

  Triple Antihypertensive Medication After Intracerebral Hemorrhage for Blood Pressure Control

  Not yet reported The University of Hong Kong 140 participants Est. completion 2030-06-30 4 sites
  Other conditions: Intracerebral Hemorrhage
  View official trial listing →
• Completed NCT NCT00000522

  Treatment of Mild Hypertension Study (TOMHS)

  Not yet reported University of Minnesota Est. completion 1994-05
  Cardiovascular disease Other conditions: Heart Diseases, Hypertension, Vascular Diseases
  View official trial listing →
• Completed NCT NCT00000542

  Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

  Not yet reported National Heart, Lung, and Blood Institute (NHLBI) Est. completion 2002-03
  Cardiovascular diseaseHeart failure Other conditions: Coronary Disease, Diabetes Mellitus, Heart Diseases, Hypercholesterolemia, Hypertension, Myocardial Ischemia
  View official trial listing →
• Completed NCT NCT00000620

  Action to Control Cardiovascular Risk in Diabetes (ACCORD)

  Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 10251 participants Est. completion 2012-12 7 sites
  Cardiovascular diseaseType 2 diabetes Other conditions: Atherosclerosis, Hypercholesterolemia, Hypertension, Diabetes Mellitus, Coronary Disease
  View official trial listing →
• Completed NCT NCT00015457

  Amlodipine Plus Botulinum Toxin for Focal Dystonia

  Not yet reported National Institute of Neurological Disorders and Stroke (NINDS) 16 participants 1 site Stand-alone
  Other conditions: Focal Dystonia
  View official trial listing →
• Completed NCT NCT00039975

  Interactions Between HIV Protease Inhibitors and Calcium Channel Blockers

  Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 32 participants Est. completion 2004-04 9 sites
  Cardiovascular disease Other conditions: HIV Infections, Hypertension
  View official trial listing →
• Completed NCT NCT00081731

  Benefits of Medical Therapy Plus Stenting for Renal Atherosclerotic Lesions

  Not yet reported Baim Institute for Clinical Research 947 participants Est. completion 2013-09 1 site
  Cardiovascular disease Other conditions: Atherosclerosis, Hypertension, Renovascular, Renal Artery Obstruction
  View official trial listing →
• Completed NCT NCT00091429

  Ranolazine SR in Patients With Chronic Angina Who Remain Symptomatic Despite Maximal Treatment With Amlodipine

  Not yet reported Gilead Sciences 500 participants Est. completion 2005-02
  Other conditions: Angina
  View official trial listing →
• Completed NCT NCT00124969

  Influence of Amlodipine on the Mortality of Patients With End-Stage Renal Failure

  Not yet reported Charite University, Berlin, Germany 356 participants Est. completion 2006-10 1 site
  Other conditions: Kidney Failure, Chronic
  View official trial listing →
• Completed NCT NCT00129233

  Comparison of Valsartan With Amlodipine in Hypertensive Patients With Glucose Intolerance

  Not yet reported Nagoya University 1150 participants Est. completion 2013-04 1 site
  Type 2 diabetes Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00136851

  Study Comparing the Efficacy of Amlodipine Besylate/Benazepril Versus Amlodipine in the Treatment of Severe Hypertension

  Not yet reported Novartis Pharmaceuticals 259 participants Est. completion 2005-07 1 site
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00139555

  Effects of Amlodipine/Benazepril in Reducing Left Ventricular Hypertrophy in Patients With High Risk Hypertension

  Not yet reported Novartis 125 participants Est. completion 2006-11 1 site
  Other conditions: Hypertension, Left Ventricular Hypertrophy
  View official trial listing →
• Completed NCT NCT00140959

  Losartan and HCTZ and Amlodipine vs Atenolol and Amlodipine (0954A-309)(COMPLETED)

  Not yet reported Organon and Co 120 participants Est. completion 2004-06-30
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00140985

  Antiproteinuric Efficacy of Losartan Potassium in Patients With Non-Diabetic Proteinuric Renal Diseases (0954-213)

  Not yet reported Organon and Co 97 participants Est. completion 2002-01
  Other conditions: Renal Disorder
  View official trial listing →
• Completed NCT NCT00142584

  Evaluation of the Long-term Safety and Tolerability of Metoprolol Versus Nebivolol in Patients With Hypertension

  Not yet reported Mylan Bertek Pharmaceuticals 336 participants Est. completion 2008-03 1 site
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00143195

  Amlodipine vs Nitrates Study in Patients With Chronic Stable Angina

  Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 200 participants Est. completion 2005-01 12 sites
  Other conditions: Myocardial Ischemia
  View official trial listing →
• Completed NCT NCT00143234

  Amlodipine/Atorvastatin Combination to Reduce the Health Risk of High Blood Pressure and High Cholesterol Levels

  Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 1825 participants Est. completion 2005-07 118 sites
  Other conditions: Hypertension, Hyperlipidemia
  View official trial listing →
• Completed NCT NCT00150384

  Clinical Utility of Caduet in Achieving Blood Pressure and Lipid Endpoints in a Specific Patient Population

  Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 500 participants Est. completion 2005-08 106 sites
  Other conditions: Hypertension, Dyslipidemia
  View official trial listing →
• Terminated NCT NCT00151619

  Effects of Amlodipine in the Management of Chronic Heart Failure

  Not yet reported Rennes University Hospital 7 participants 2 sites
  Heart failure
  View official trial listing →
• Completed NCT NCT00156403

  A Pilot Study of Use of Calcium Channel Blocker to Decrease Inflammation and Pain in Hereditary Pancreatitis

  Not yet reported, Not yet reported University of Pittsburgh 8 participants Est. completion 2005-12 1 site
  Other conditions: Pancreatitis
  View official trial listing →
• Completed NCT NCT00157963

  Hydrochlorothiazide (+) Losartan Potassium vs. Amlodipine Comparative Study (0954A-314)

  Not yet reported Organon and Co 174 participants Est. completion 2006-02-08
  Other conditions: Essential Hypertension
  View official trial listing →
• Completed NCT NCT00159692

  Amlodipine Diabetic Hypertension Efficacy Response Trial

  Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 739 participants Est. completion 2005-08
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00160212

  Study to Evaluate the Efficacy and Safety of SLV306 in Subjects With Hypertension

  Not yet reported Solvay Pharmaceuticals 130 sites
  Other conditions: Hypertension
  View official trial listing →
• Terminated NCT NCT00170950

  Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension

  Not yet reported Novartis 11506 participants Est. completion 2008-05 5 sites Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00170963

  Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Valsartan Alone

  Not yet reported Novartis 1018 participants Est. completion 2005-06 2 sites
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00170976

  A Year Long Study to Evaluate the Safety of the Combination of Valsartan (320 mg) and Amlodipine (5 mg) in Patients With Hypertension

  Not yet reported Novartis 403 participants Est. completion 2005-06 2 sites
  Other conditions: HYPERTENSION
  View official trial listing →
• Completed NCT NCT00171002

  Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Amlodipine Alone

  Not yet reported Novartis 936 participants Est. completion 2005-06 2 sites
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00171366

  A Study Comparing the Response of Patients With Hypertension to Amlodipine or Amlodipine Plus Benazepril.

  Not yet reported Novartis 1422 participants Est. completion 2005-07 1 site
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00171535

  Efficacy and Safety of Valsartan/Amlodipine Combination in Patients With Severe Hypertension

  Not yet reported Novartis 130 participants Est. completion 2005-04 1 site
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00174304

  Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia.

  Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 1120 participants Est. completion 2006-09 102 sites
  Other conditions: Hypertension, Hyperlipidemia
  View official trial listing →
• Completed NCT NCT00174330

  Comparing Amlodipine/Atorvastatin Co-Administration To Amlodipine Alone In Patients With Hypertension And Dyslipidemia

  Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 330 participants Est. completion 2006-02 15 sites
  Other conditions: Hypertension, Hyperlipidemia
  View official trial listing →
• Completed NCT NCT00185120

  Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker

  Not yet reported Daiichi Sankyo 152 participants Est. completion 2006-09 20 sites
  Other conditions: Hypertension
  View official trial listing →
• Status unknown NCT NCT00202618

  Rationale and Design for Shiga Microalbuminuria Reduction Trial

  Not yet reported Shiga University 160 participants Est. completion 2006-06 1 site
  Other conditions: Hypertension, Diabetes Mellitus, Albuminuria
  View official trial listing →
• Completed NCT NCT00219076

  A Clinical Study to Evaluate the Safety and Efficacy of the Combination of Aliskiren and Amlodipine in Hypertensive Non Responders Patients

  Not yet reported Novartis 504 participants 2 sites
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00219154

  A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazidebased Treatment Regimen With Optional Addition of Amlodipine

  Not yet reported Novartis 1125 participants Est. completion 2006-01 2 sites
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00220220

  Amlodipine as add-on to Olmesartan in Hypertension

  Not yet reported Sankyo Pharma Gmbh 429 participants Est. completion 2007-04 6 sites
  Other conditions: Essential Hypertension
  View official trial listing →
• Completed NCT NCT00220233

  Olmesartan as an add-on to Amlodipine in Hypertension

  Not yet reported Sankyo Pharma Gmbh 632 participants Est. completion 2007-08 5 sites
  Other conditions: Essential Hypertension
  View official trial listing →
• Completed NCT NCT00231803

  The Canadian Prevention of Renal and Cardiovascular Endpoints Trial

  Not yet reported Brendan Barrett 474 participants Est. completion 2008-06 5 sites Stand-alone
  Chronic kidney disease
  View official trial listing →
• Completed NCT NCT00234871

  Tarka® vs. Lotrel® in Hypertensive, Diabetic Subjects With Renal Disease (TANDEM)

  Not yet reported Abbott 357 participants
  Other conditions: Hypertension, Diabetes, Proteinuria
  View official trial listing →
• Completed NCT NCT00237588

  Glucose Optimisation With Angiotensin II Antagonist Losartan (GOAAL)

  Not yet reported Ullevaal University Hospital 25 participants Est. completion 2005-07 1 site
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00240474

  A Comparison of Telmisartan + Hydrochlorothiazide With Amlodipine + Hydrochlorothiazide in the Control of Blood Pressure in Older Patients With Predominantly Systolic Hypertension (ATHOS Study)

  Not yet reported Boehringer Ingelheim 1000 participants Est. completion 2004-03 73 sites
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00242814

  Phase IV, 9 Weeks Comparison Between MICARDIS 80 mg and Amlodipine 10 mg on Biological PPAR Gamma Activities

  Not yet reported Boehringer Ingelheim 100 participants 31 sites
  Metabolic syndrome Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00289406

  Efficacy and Safety Study of S-Amlodipine Gentisate Compared to Amlodipine Besylate to Treat Mild-to-Moderate Hypertension

  Not yet reported SK Chemicals Co., Ltd. 110 participants Est. completion 2006-02 1 site
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00294710

  A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazide Based Treatment Regimen With Optional Addition of Amlodipine

  Not yet reported Novartis 976 participants Est. completion 2006-07 2 sites
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00304226

  Effectiveness of a Valsartan Based Versus an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy

  Not yet reported Novartis 1288 participants Est. completion 2007-01 2 sites
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00311155

  Olmesartan and an add-on Treatment in Patients With Mild to Moderate Hypertension

  Not yet reported Sankyo Pharma Gmbh 694 participants Est. completion 2008-04 79 sites Stand-alone
  Other conditions: Essential Hypertension
  View official trial listing →
• Terminated NCT NCT00313547

  High-Dose Quinapril Versus Low-Dose Quinapril Plus Amlodipine in the Treatment of High-Risk Hypertensive Patients

  Not yet reported Montreal Heart Institute 40 participants Est. completion 2008-03 1 site
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00327145

  A Study to Evaluate the Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled on Monotherapy

  Not yet reported Novartis 894 participants Est. completion 2007-01 1 site
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00330785

  Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension and Dyslipidaemia

  Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 1250 participants Est. completion 2005-09 126 sites
  Other conditions: Hypertension, Dyslipidemia
  View official trial listing →
• Completed NCT NCT00332761

  Caduet in an Untreated Subject Population

  Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 220 participants Est. completion 2007-09 34 sites
  Other conditions: Hypertension, Dyslipidemia
  View official trial listing →
• Completed NCT NCT00333489

  Comparative Study of Valsartan and Amlodipine Versus Amlodipine Alone in Hypertension

  Not yet reported Novartis 551 participants Est. completion 2005-04 1 site
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00337298

  The Effect of Amlodipine and Lisinopril on Retinal Autoregulation in Type 1 Diabetes

  Not yet reported University of Aarhus 25 participants Est. completion 2009-02 1 site Stand-alone
  Other conditions: Type 1 Diabetes, Diabetic Retinopathy, Eye Diseases, Diabetes Complications
  View official trial listing →
• Completed NCT NCT00338338

  The Efficacy And Safety Of Lacidipine And Amlodipine Once-Daily Treatment In Hypertensive Adult Patients

  Not yet reported GlaxoSmithKline 70 participants Est. completion 2007-09-14 1 site
  Other conditions: Uncomplicated Hypertension, Hypertension, Essential
  View official trial listing →
• Completed NCT NCT00350168

  Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Patients With Stage II Hypertension

  Not yet reported Novartis 647 participants Est. completion 2007-04 1 site
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00351130

  Effectiveness of a Valsartan Based vs an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy

  Not yet reported Novartis 79 participants Est. completion 2007-03 2 sites
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00360178

  Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus Hydrochlorothiazide

  Not yet reported Novartis 198 participants Est. completion 2006-12 2 sites
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00367939

  Efficacy and Safety of the Combination of Valsartan Plus Amlodipine in Hypertensive Patients Not Adequately Responding to the Combination Therapy With Ramipril Plus Felodipine

  Not yet reported Novartis 132 participants Est. completion 2006-07 1 site
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00368277

  A Safety and Efficacy Trial of Aliskiren 150mg , 300 mg Compared to Ramipril 5mg, 10mg in the Elderly

  Not yet reported Novartis Pharmaceuticals 901 participants Est. completion 2008-02 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00382421

  Study to Investigate Effects of Antiischemic Drug Therapy in Silent Ischemia

  Not yet reported Luzerner Kantonsspital Est. completion 2006-04 1 site
  Other conditions: Myocardial Ischemia
  View official trial listing →
• Completed NCT NCT00402103

  An Assessment of Long Term Safety of the Combination of Aliskiren / Amlodipine in Patients With High Blood Pressure

  Not yet reported Novartis 556 participants Est. completion 2008-04 8 sites Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00407537

  Caduet vs Usual Care in Subjects With Hypertension and Additional Risk Factors

  Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 1531 participants Est. completion 2009-10 125 sites Stand-alone
  Other conditions: Hypertension, Hypercholesterolemia
  View official trial listing →
• Completed NCT NCT00409760

  Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Patients With Hypertension.

  Not yet reported Novartis 1930 participants Est. completion 2004-02 1 site
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00409851

  One Year Study to Evaluate the Safety of the Combination of Valsartan and Amlodipine in Patients With Hypertension

  Not yet reported Novartis 1293 participants Est. completion 2005-03 2 sites
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00413049

  Efficacy/Safety of Valsartan Plus Amlodipine and Amlodipine Alone in Patients With Hypertension

  Not yet reported Novartis 698 participants Est. completion 2007-11 12 sites Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00415623

  A Comparative Study Between Amlodipine 10mg And 5mg With Hypertension For Whom 5mg Is Insufficient

  Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 305 participants Est. completion 2007-10 14 sites Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00417170

  Comparison of Aliskiren and Amlodipine on Insulin Resistance and Endothelial Dysfunction in Patients With Hypertension and Metabolic Syndrome

  Not yet reported Novartis Pharmaceuticals 48 participants Est. completion 2010-07 1 site Stand-alone
  Metabolic syndrome Other conditions: High Blood Pressure, Insulin Resistance, Endothelial Dysfunction
  View official trial listing →
• Completed NCT NCT00421863

  Italian Study on the Cardiovascular Effects of Systolic Blood Pressure Control - CARDIOSIS Study

  Not yet reported Heart Care Foundation 1111 participants Est. completion 2009-01 45 sites
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00425373

  Efficacy and Safety of Valsartan and Amlodipine in Patients With Essential Hypertension

  Not yet reported, Not yet reported Novartis Pharmaceuticals 1474 participants Est. completion 2008-03 1 site Stand-alone
  Other conditions: Essential Hypertension
  View official trial listing →
• Completed NCT NCT00425997

  Efficacy of Valsartan/Hydrochlorothiazide Versus Amlodipine and Hydrochlorothiazide in Patients Hypertension

  Not yet reported Novartis 480 participants Est. completion 2007-10 1 site
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00426478

  Safety and Efficacy of Valsartan Plus Hydrochlorothiazide and Amlodipine in Hypertensive Patients

  Not yet reported Novartis 80 participants Est. completion 2007-09 1 site
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00437645

  Efficacy and Safety of Valsartan/Amlodipine Compared to Amlodipine in Patients With Essential Hypertension

  Not yet reported Novartis Pharmaceuticals 1183 participants Est. completion 2007-11 12 sites Stand-alone
  Other conditions: Essential Hypertension
  View official trial listing →
• Completed NCT NCT00438113

  Atrial Substrate Modification With Aggressive Blood Pressure Lowering to Prevent AF

  Not yet reported Nova Scotia Health Authority 184 participants Est. completion 2016-09 1 site
  Other conditions: Atrial Fibrillation
  View official trial listing →
• Completed NCT NCT00439738

  Safety/Efficacy of Valsartan/Hydrochlorothiazide Combination Compared to Hydrochlorothiazide in Obese Hypertensive Adults

  Not yet reported Novartis Pharmaceuticals 412 participants 5 sites
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00443456

  Long Term Study Of Amlodipine 10mg With Hypertension For Whom Amlodipine 5mg Is Insufficient

  Not yet reported Pfizer 134 participants Est. completion 2008-06 9 sites Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00446524

  Long Term Study of Valsartan and Amlodipine in Patients With Essential Hypertension (Extension to Study CVAA489A1301)

  Not yet reported Novartis 403 participants Est. completion 2008-10 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00446563

  Efficacy and Safety of Valsartan in Combination With Amlodipine Compared to Losartan Plus Hydrochlorothiazide in Patients With Hypertension and Left Ventricular Hypertrophy

  Not yet reported Novartis 90 participants Est. completion 2010-03 1 site Stand-alone
  Other conditions: Hypertension; Hypertrophy, Left Ventricular
  View official trial listing →
• Completed NCT NCT00454662

  Combination of OLMesartan and CCB or Low Dose Diuretics in High Risk Elderly Hypertensive Patients Study (COLM-Study)

  Not yet reported COLM Study Research Organization 5141 participants Est. completion 2011-09 1 site
  Cardiovascular disease Other conditions: Hypertension, Diabetes
  View official trial listing →
• Completed NCT NCT00460915

  Efficacy and Safety of Lacidipine and Amlodipine on Blood Pressure in Korean ISH Patients Aged 60 to 80 Years

  Not yet reported Korea University Guro Hospital 204 participants Est. completion 2010-02 1 site
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00492128

  Kanagawa Combination Anti-hypertensive Therapy (K-CAT)

  Not yet reported Yokohama City University Medical Center 196 participants Est. completion 2010-08 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00509470

  Evaluation of Effect of Combination With Telmisartan and Hydrochlorothiazide in Hypertensives Uncontrolled on Amlodipine

  Not yet reported Tokyo University 75 participants Est. completion 2012-10 1 site
  Other conditions: Essential Hypertension
  View official trial listing →
• Completed NCT NCT00518479

  Pathophysiological Mechanisms of Hypertensive LVH:Optimising Regression

  Not yet reported University of Leeds 42 participants Est. completion 2004-04 1 site Stand-alone
  Other conditions: Hypertension, Left Ventricular Hypertrophy
  View official trial listing →
• Completed NCT NCT00523744

  Efficacy and Safety of Valsartan and Amlodipine (± HCTZ) in Adults With Moderate, Inadequately Controlled Hypertension

  Not yet reported Novartis 257 participants Est. completion 2007-12 2 sites Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00535925

  Nephropathy In Type 2 Diabetes and Cardio-renal Events

  Not yet reported University of Campania Luigi Vanvitelli 850 participants Est. completion 2019-05 1 site Stand-alone
  Chronic kidney disease
  View official trial listing →
• Completed NCT NCT00538486

  A Randomized, Double-Blind, Active Control Trial Comparing Effects of Telmisartan, Candesartan and Amlodipine, Alone or Plus Metformin, on Non-Diabetic, Obese Hypertensive Patients

  Not yet reported Third Military Medical University 360 participants Est. completion 2009-06 1 site Stand-alone
  Other conditions: Hypertension, Obesity
  View official trial listing →
• Completed NCT NCT00548067

  Pharmacokinetic Drug Interaction Study Following Co-administration of Valsartan, Hydrochlorothiazide and Amlodipine in Patients With Hypertension

  Not yet reported Novartis 111 participants Est. completion 2008-03 5 sites Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00550953

  Filtered Trial for Telmisartan 40mg Non-responder

  Not yet reported Boehringer Ingelheim 314 participants 5 sites
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00558064

  Filtered Trial for Amlodipine Non-responder

  Not yet reported Boehringer Ingelheim 531 participants 41 sites
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00568178

  An Extension Study Designed to Assess Effects of Losartan on Proteinuria in Pediatric Populations (MK-0954-326 AM1,EXT1(AM2))

  Not yet reported Organon and Co 306 participants Est. completion 2011-03-01 Stand-alone
  Other conditions: Proteinuria
  View official trial listing →
• Terminated NCT NCT00579254

  Real Life Experience With Caduet In Patients With Cardiovascular Risk Factors

  Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 112 participants Est. completion 2008-05
  Other conditions: Hypertension and Cardiovascular Risk Factors
  View official trial listing →
• Completed NCT NCT00591266

  Efficacy and Safety of Azilsartan Medoxomil, Once Daily (QD), Co-Administered With Amlodipine in Participants With Essential Hypertension

  Not yet reported Takeda 566 participants Est. completion 2009-04 50 sites Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00601302

  Bioequivalency Study of Amlodipine Tablets Under Fed Conditions

  Not yet reported Roxane Laboratories 40 participants Est. completion 2004-05 1 site
  Other conditions: Hypertension, Chronic Stable Angina, Vasospastic Angina
  View official trial listing →
• Completed NCT NCT00614380

  Open Label Study Telmisartan and Amlodipine in Hypertension

  Not yet reported Boehringer Ingelheim 976 participants 122 sites
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00618774

  An Open-label, Long-term Study of Telmisartan Plus Amlodipine Fixed-dose Combination

  Not yet reported Boehringer Ingelheim 259 participants 7 sites
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00627952

  A Study to Evaluate the Effects of Manidipine Versus Amlodipine and the Combination of Manidipine Plus Delapril Versus Amlodipine Plus Delapril on Intraglomerular Pressure in Hypertensive Patients

  Not yet reported University of Erlangen-Nürnberg Medical School 100 participants Est. completion 2008-12 1 site
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00631514

  Interaction Between Antihypertensives and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

  Not yet reported University of Split 88 participants Est. completion 2006-09 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00637078

  STITCH2 (Simplified Therapeutic Intervention to Control Hypertension and Hypercholesterolemia)

  Not yet reported University of Western Ontario, Canada 1000 participants Est. completion 2010-12 1 site
  Other conditions: Hypertension, Hypercholesterolemia
  View official trial listing →
• Completed NCT NCT00649389

  Safety and Efficacy Study of a Triple Combination Therapy in Subjects With Hypertension

  Not yet reported Daiichi Sankyo 2500 participants Est. completion 2009-12 232 sites Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00649519

  Fasting Study of Amlodipine and Benazepril HCl Capsules 10 mg/20 mg to Lotrel® Capsules 10 mg/20 mg

  Not yet reported Mylan Pharmaceuticals Inc 54 participants Est. completion 2004-05 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Withdrawn NCT NCT00656331

  The Pleiotropic Effects of Atorvastatin When Combined With Common Antihypertenisve Medications.

  Not yet reported University of New Mexico Est. completion 2012-06 1 site
  Other conditions: Hypertension
  View official trial listing →
• Status unknown NCT NCT00659451

  Effects Of Losartan On Myocardial Structure In Diabetic Hypertensive Patients With Left Ventricular

  Not yet reported University of Pavia 100 participants Est. completion 2009-04 1 site
  Other conditions: Essential Hypertension, Diabetes Mellitus
  View official trial listing →
• Completed NCT NCT00661895

  Black Education and Treatment of Hypertension (BEAT HTN)

  Not yet reported Creighton University 99 participants Est. completion 2009-11 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Status unknown NCT NCT00669435

  Losartan and Simvastatin in Hypertensive Obeses With Liver Steatosis

  Not yet reported University of Pavia 75 participants Est. completion 2009-04 1 site
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00684489

  Renin-Guided Therapeutics in the Management of Untreated, Uncontrolled, or Complicated Hypertension

  Not yet reported Medical University of South Carolina 52 participants Est. completion 2005-09
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00693199

  Effect of Amlodipine Monotherapy or Combined With Terazosin on Lower Urinary Tract Symptoms and Hypertension

  Not yet reported Anhui Medical University 360 participants Est. completion 2006-10 1 site Stand-alone
  Other conditions: Lower Urinary Tract Symptoms, Hypertension
  View official trial listing →
• Completed NCT NCT00699192

  Safety, Tolerability, and Efficacy of Once Daily Amlodipine/Valsartan 5/80 as Compared to Amlodipine/Valsartan 5/40 or to Amlodipine 5 mg Monotherapy in Patients 65 Years of Age and Older With Essential Hypertension

  Not yet reported Novartis Pharmaceuticals 965 participants Est. completion 2009-05 18 sites Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00700271

  Efficacy of a Combination of Amlodipine/Valsartan on 24H Blood Pressure Control With One Nocturnal or Diurnal Intake a Day

  Not yet reported Novartis Pharmaceuticals 478 participants Est. completion 2008-08 2 sites Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00739596

  Blood Pressure Lowering of Aliskiren Hydrochlorothiazide (HCTZ) Versus Amlodipine in Stage 2 Hypertension in African Americans

  Not yet reported Novartis Pharmaceuticals 332 participants Est. completion 2009-03 1 site
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00741585

  Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk Assessment

  Not yet reported University of Vigo 21983 participants Est. completion 2018-06-30 20 sites
  Cardiovascular diseaseChronic kidney disease Other conditions: Essential Hypertension
  View official trial listing →
• Withdrawn NCT NCT00745953

  Regression of Fatty Heart by Valsartan Therapy

  Not yet reported University of Texas Southwestern Medical Center Est. completion 2009-08 1 site
  Metabolic syndrome Other conditions: Lipotoxicity
  View official trial listing →
• Completed NCT NCT00772499

  Vascular Improvement With Olmesartan Medoxomil Study

  Not yet reported Daiichi Sankyo 100 participants Est. completion 2005-07 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00775151

  Bioequivalence Study of Amlodipine 10mg Tablets Under Fed Conditions

  Not yet reported Ranbaxy Laboratories Limited 40 participants Est. completion 2005-11 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT00775905

  Bioequivalence Study of Amlodipine Tablets Under Fasting Conditions

  Not yet reported Ranbaxy Laboratories Limited 40 participants Est. completion 2005-10 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT00777946

  Study to Evaluate the Efficacy and Safety of Combination Aliskiren/Amlodipine in Patients Not Adequately Responding to Aliskiren Alone

  Not yet reported Novartis 818 participants Est. completion 2009-05 9 sites Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00778921

  Study to Evaluate the Efficacy and Safety of Combination Aliskiren/Amlodipine in Patients With Hypertension Not Adequately Responding to Amlodipine Alone

  Not yet reported Novartis 847 participants Est. completion 2009-06 7 sites Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00787605

  Aliskiren HCTZ Compared to Amlodipine in Patients With Stage 2 Systolic Hypertension and Diabetes Mellitus

  Not yet reported Novartis 860 participants Est. completion 2010-01 1 site
  Other conditions: Hypertension, Diabetes Mellitus
  View official trial listing →
• Completed NCT NCT00791258

  A Dose Escalation Study of a Combination Antihypertensive Drug in the Treatment of Various Groups of Patients Who do Not Respond to Single Drug Treatment of Their High Blood Pressure

  Not yet reported Daiichi Sankyo 999 participants Est. completion 2009-09 72 sites Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00797862

  Aliskiren and the Calcium Channel Blocker Amlodipine Combination as an Initial Treatment Strategy for Hypertension

  Not yet reported Novartis 1254 participants Est. completion 2010-11 10 sites Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Terminated NCT NCT00805311

  Aggressive Medical Treatment Evaluation for Asymptomatic Carotid Artery Stenosis

  Not yet reported Russian Cardiology Research and Production Center 400 participants Est. completion 2014-05 2 sites Stand-alone
  Cardiovascular disease Other conditions: Carotid Artery Stenosis, Atherosclerosis
  View official trial listing →
• Status unknown NCT NCT00813722

  Effect of Active Telephone Calls in the Compliance of Hypertensive Patients With Treatment

  Not yet reported University of Sao Paulo 400 participants Est. completion 2009-06 2 sites
  Other conditions: Blood Pressure
  View official trial listing →
• Completed NCT NCT00819104

  A Study to Compare the Efficacy, Safety and Tolerability of Selomax With Its Individual Components

  Not yet reported AstraZeneca 402 participants Est. completion 2009-08 11 sites Stand-alone
  Other conditions: Primary Hypertension
  View official trial listing →
• Completed NCT NCT00834977

  Amlodipine-Benazepril 10mg-20mg Capsules in Healthy Subjects Under Fasting Conditions

  Not yet reported Teva Pharmaceuticals USA 48 participants Est. completion 2004-05 2 sites Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT00841815

  Amlodipine 10 mg Tablets Under Fed Conditions

  Not yet reported Teva Pharmaceuticals USA 28 participants Est. completion 2003-05 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT00847262

  Trial Comparing Metabolic Effects of Telmisartan and Amlodipine on Hypertensive Patients With Obesity and Diabetes

  Not yet reported Third Military Medical University 120 participants Est. completion 2009-06 1 site
  Other conditions: Hypertension, Obesity, Diabetes
  View official trial listing →
• Completed NCT NCT00853957

  Efficacy and Safety of Aliskiren Administered in Combination With Amlodipine Versus Amlodipine Alone in African American Patients With Stage 2 Hypertension

  Not yet reported Novartis 443 participants Est. completion 2009-08 9 sites Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00860262

  Telmisartan and Amlodipine Fixed Dose Combination [FDC] Trial for the Treatment of Severe Hypertension

  Not yet reported Boehringer Ingelheim 858 participants 137 sites Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00867490

  Safety and Efficacy of Aliskiren + Hydrochlorothiazide (± Amlodipine 5 mg) in Patients With Moderate Hypertension

  Not yet reported Novartis 186 participants Est. completion 2009-08 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00870142

  A Relative Bioavailability Study of Amlodipine Besylate 10 mg Tablets Under Fasting Conditions

  Not yet reported Actavis Inc. 26 participants Est. completion 2005-05 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT00870571

  A Relative Bioavailability Study of Amlodipine Besylate 10 mg Tablets Tablets Under Fed Conditions

  Not yet reported Actavis Inc. 26 participants Est. completion 2005-05 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT00890591

  Efficacy and Safety of Olmesartan Medoxomil in Stage 1 and 2 Essential Hypertension

  Not yet reported Daiichi Sankyo 144 participants Est. completion 2007-08 Stand-alone
  Other conditions: Essential Hypertension
  View official trial listing →
• Completed NCT NCT00921570

  The Effects of Renin Angiotensin System Blockage (RAS), Calcium Channel Blocker and Combined Drugs on TWEAK, PTX3 and FMD Levels in Diabetic Proteinuric Patients With Hypertension

  Not yet reported Gulhane School of Medicine 105 participants Est. completion 2009-05 1 site Stand-alone
  Other conditions: Diabetes, Hypertension, Proteinuria
  View official trial listing →
• Completed NCT NCT00923091

  Parallel-Group Comparison of Olmesartan (OLM), Amlodipine (AML) and Hydrochlorothiazid (HCTZ) in Hypertension

  Not yet reported Daiichi Sankyo 2689 participants Est. completion 2011-03 133 sites Stand-alone
  Other conditions: Essential Hypertension
  View official trial listing →
• Completed NCT NCT00931710

  Valsartan/Amlodipine As Compared to Losartan Treatment in Stage 2 Systolic Hypertension

  Not yet reported Novartis 488 participants Est. completion 2010-01 1 site Stand-alone
  Other conditions: Stage 2 Systolic Hypertension
  View official trial listing →
• Completed NCT NCT00932763

  Study to Evaluate the Bioavailability of the Test Formulation of Amlodipine 10 mg Tablets (Torrent Pharmaceuticals Limited) Compared to a 10 mg Dose of Norvasc® (Pfizer) in 22 Fasted, Healthy Adult Subjects

  Not yet reported Torrent Pharmaceuticals Limited 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT00932880

  Study to Evaluate the Bioavailability of the Test Formulation of Amlodipine 10 mg Tablets (Torrent Pharmaceuticals Limited) Compared to a 10 mg Dose of Norvasc® (Pfizer) in 18 Fed, Healthy Adult Subjects

  Not yet reported Torrent Pharmaceuticals Limited 1 site
  Other conditions: Healthy
  View official trial listing →
• Status unknown NCT NCT00935805

  Glycemic And Blood Pressure Control In Type 2 Diabetes, In A Primary Care Unit: A Staged Management Strategy

  Hospital de Clinicas de Porto Alegre 124 participants Est. completion 2012-07 1 site
  Other conditions: Diabetes Mellitus, Arterial Hypertension
  View official trial listing →
• Completed NCT NCT00938197

  A Study to Evaluate the Pharmacokinetic Drug Interaction After Oral Concurrent Administration of Fimasartan and Amlodipine in Healthy Male Volunteers

  Not yet reported Boryung Pharmaceutical Co., Ltd 34 participants Est. completion 2009-08 1 site
  Other conditions: Essential Hypertension
  View official trial listing →
• Completed NCT NCT00940667

  Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Essential Hypertension

  Not yet reported Hanmi Pharmaceutical Company Limited 185 participants Est. completion 2008-12 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00940680

  Efficacy/Safety of Amlodipine Plus Losartan Versus Losartan in Patients With Essential Hypertension

  Not yet reported Hanmi Pharmaceutical Company Limited 142 participants Est. completion 2008-11 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00950066

  Irbesartan and Amlodipine Combination in Controlling Blood Pressure

  Not yet reported Sanofi 270 participants Est. completion 2010-01 4 sites
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00956644

  Irbesartan/Amlodipine in Hypertensive Patients Uncontrolled on Amlodipine 5 mg Monotherapy

  Not yet reported Sanofi 406 participants Est. completion 2010-08 40 sites Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Withdrawn NCT NCT00987662

  Irbesartan Versus Amlodipine: The OBI Study

  Not yet reported Aristotle University Of Thessaloniki Est. completion 2014-01 1 site
  Other conditions: Obesity, Hypertension
  View official trial listing →
• Completed NCT NCT01001572

  Efficacy and Safety of Valsartan/Amlodipine in Patients With Mild to Moderate Essential Hypertension

  Not yet reported Novartis 932 participants Est. completion 2010-05 2 sites Stand-alone
  Other conditions: Essential Hypertension
  View official trial listing →
• Completed NCT NCT01004614

  Bioequivalence Study For 5 Mg Amlodipine Orally-Disintegrating Tablet

  Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 48 participants Est. completion 2009-12 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Status unknown NCT NCT01011660

  Effects of Angiotensin II Receptor Blocker Compared With Diuretics in High-risk Hypertensive Patients

  Not yet reported Chinese Academy of Medical Sciences, Fuwai Hospital 13542 participants Est. completion 2012-12 1 site
  Other conditions: Essential Hypertension
  View official trial listing →
• Completed NCT NCT01030081

  Amlodipine Prevents Morning Blood Pressure Surge Study

  Not yet reported Shanghai Jiao Tong University School of Medicine 510 participants Est. completion 2013-03 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT01041807

  Cozaar XQ Re-examination Study (MK-0954-349)

  Organon and Co 669 participants Est. completion 2015-03
  Other conditions: Hypertension
  View official trial listing →
• Status unknown NCT NCT01048047

  Effects of Aliskiren/Amlodipine Versus Amlodipine Monotherapy on Ankle-foot Volume in Hypertensive Patients

  Not yet reported University of Pavia 88 participants Est. completion 2010-03 2 sites Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT01070043

  To Demonstrate Non-inferiority of Combination of 5 mg Amlodipine/ 80 mg Valsartan to 160 mg Valsartan Alone

  Not yet reported Novartis 60 participants Est. completion 2010-09 1 site Stand-alone
  Other conditions: Hypertension, High Blood Pressure
  View official trial listing →
• Terminated NCT NCT01080768

  Assessment of Aliskiren/Amlodipine and Amlodipine on Ankle Foot Volume (AFV) in Patients With Hypertension

  Not yet reported Novartis Pharmaceuticals 31 participants Est. completion 2010-11 9 sites Stand-alone
  Other conditions: Hypertension, Ankle Edema
  View official trial listing →
• Completed NCT NCT01083017

  Resistant Arterial Hypertension Cohort Study

  University Hospital, Geneva 74 participants Est. completion 2017-05 3 sites
  Other conditions: Hypertension, Essential Hypertension, Resistant Hypertension
  View official trial listing →
• Completed NCT NCT01091753

  Effect of Nocturnal Administration of Anti-hypertensive Medications in NoN-dippers

  Not yet reported Yonsei University 28 participants Est. completion 2009-09 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT01101009

  Comparison of Sevikar® and the Combination of Perindopril/Amlodipine on Central Blood Pressure

  Not yet reported Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 486 participants Est. completion 2012-12 15 sites
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT01103960

  An Eight-week Randomized,Double-blind Study to Evaluate the Efficacy and Safety of Fixed-dose Combinations of T80+A5 Versus A5 Monotherapy in Patients With Hypertension Who Fail to Respond Adequately to Treatment With A5 Monotherapy

  Not yet reported Boehringer Ingelheim 324 participants 16 sites
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT01107743

  Amlodipine/Atorvastatin (Caduet®) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)

  Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 1291 participants Est. completion 2012-04
  Other conditions: Hypertension, Angina Pectoris, Hypercholesterolemia, Familial Hypercholesterolemia
  View official trial listing →
• Completed NCT NCT01113047

  Aliskiren in Combination With Amlodipine in Hypertensive Patients Not Responding to Angiotensin Receptor Blocker (ARB) Plus Amlodipine

  Not yet reported Novartis 347 participants 1 site Stand-alone
  Other conditions: Essential Hypertension
  View official trial listing →
• Completed NCT NCT01117038

  Drug Interaction Study of Avanafil and Enalapril or Amlodipine

  Not yet reported VIVUS LLC 48 participants Est. completion 2010-05 1 site Stand-alone
  Other conditions: Erectile Dysfunction
  View official trial listing →
• Completed NCT NCT01125254

  Amlodipine Use in the Prevention and Treatment of Iron Overload in Patients With Thalassemia Major

  Not yet reported, Not yet reported University of Campinas, Brazil 10 participants Est. completion 2011-07 1 site Stand-alone
  Other conditions: Thalassemia Major
  View official trial listing →
• Completed NCT NCT01128322

  CKD-828 Primary Hypertension Trial(Dose-selection)

  Not yet reported Chong Kun Dang Pharmaceutical 430 participants Est. completion 2011-03 26 sites Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT01130168

  The Effects of Antihypertensive Agents on Central Blood Pressure in Healthy Participants and Participants With Hypertension (MK-0000-166) (COMPLETED)

  Not yet reported Merck Sharp & Dohme LLC 38 participants Est. completion 2010-11 Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT01131546

  Efficacy and Safety of Levamlodipine Besylate Compared to Amlodipine Maleate in Patients With Essential Hypertension

  Not yet reported Jiangsu Simcere Pharmaceutical Co., Ltd. 1080 participants Est. completion 2011-03 1 site
  Other conditions: Essential Hypertension
  View official trial listing →
• Completed NCT NCT01131923

  Bioequivalency Study of Amlodipine Besylate Tablets, 10 mg of Dr. Reddy's Under Fasting Conditions

  Not yet reported Dr. Reddy's Laboratories Limited 26 participants Est. completion 2002-12 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT01131936

  Bioequivalency Study of Amlodipine Besylate Tablets, 10 mg of Dr. Reddy's Under Fed Conditions

  Not yet reported Dr. Reddy's Laboratories Limited 24 participants Est. completion 2002-11 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT01134393

  TElmisartan and AMlodipine Single Pill sTudy With Patients Not on Goal With Mono rAas Therapy-switch

  Not yet reported Boehringer Ingelheim 502 participants 47 sites Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT01155895

  Bioequivalence Study of 10 mg Amlodipine Besylate/ 20 mg Benazepril Hydrochloride Capsules of Dr.Reddys Laboratories Limited Under Fasting Conditions

  Not yet reported Dr. Reddy's Laboratories Limited 54 participants Est. completion 2004-04 Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT01176032

  ALiskiren or Losartan Effects on bioMARKers of Myocardial Remodeling

  Not yet reported Novartis Pharmaceuticals 74 participants Est. completion 2013-04 25 sites Stand-alone
  Other conditions: Hypertension, Left Ventricle Hypertrophy
  View official trial listing →
• Status unknown NCT NCT01180205

  Telmisartan, Amlodipine and Flow Mediated Dilation

  Not yet reported Johannes Gutenberg University Mainz 576 participants Est. completion 2011-10 1 site
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT01181011

  Telmisartan, Amlodipine and Combination in Healthy Subjects

  Not yet reported Boehringer Ingelheim 28 participants 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT01190007

  Open Label Study To Evaluate The Long-Term Safety Profiles Of Caduet In Japanese Patients

  Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 159 participants Est. completion 2012-02 20 sites
  Other conditions: Hypertension, Hypercholesterolemia, Angina Pectoris
  View official trial listing →
• Completed NCT NCT01197001

  A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and Losartan

  Not yet reported Hanmi Pharmaceutical Company Limited 72 participants Est. completion 2010-11 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT01197014

  A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and Losartan

  Not yet reported Hanmi Pharmaceutical Company Limited 72 participants Est. completion 2010-12 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT01198249

  Pharmacokinetic Drug Interactions Between Single and Concomitant Administrations of Amlodipine, Losartan, and Hydrochlorothiazide in Subjects With (Pre)Hypertension

  Not yet reported Yonsei University 23 participants Est. completion 2011-03 1 site Stand-alone
  Other conditions: Essential Hypertension
  View official trial listing →
• Terminated NCT NCT01200407

  Amlodipine And Olmesartan Medoxomil In Hypertensive Filipino Patients

  Pfizer 615 participants Est. completion 2014-01-04 51 sites
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT01203696

  Effect of Amlodipine on Anti-platelet Drug Effect in Patients With Coronary Artery Disease

  Not yet reported Ruttonjee Hospital 97 participants Est. completion 2011-04 1 site
  Other conditions: Ischemic Heart Disease
  View official trial listing →
• Completed NCT NCT01222520

  Telmisartan 80mg Non-responder Trial

  Not yet reported Boehringer Ingelheim 174 participants 4 sites Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT01237223

  Efficacy and Safety of SPA100 (Fixed-dose Combination of Aliskiren/Amlodipine) in Patients With Essential Hypertension

  Not yet reported Novartis 1342 participants Est. completion 2011-05 11 sites Stand-alone
  Other conditions: Essential Hypertension
  View official trial listing →
• Completed NCT NCT01237873

  Long Term Safety of SPA100 (Fixed-dose Combination of Aliskiren/Amlodipine) in Patients With Essential Hypertension

  Not yet reported Novartis Pharmaceuticals 150 participants Est. completion 2012-02 13 sites Stand-alone
  Other conditions: Essential Hypertension
  View official trial listing →
• Completed NCT NCT01241487

  A National Multicentre Study to Assess the Efficacy of the Fixed Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled by Monotherapy

  Not yet reported Novartis 150 participants Est. completion 2011-01 1 site Stand-alone
  Other conditions: Primary Hypertension
  View official trial listing →
• Completed NCT NCT01243268

  A Regulatory Requirement Post-Marketing Surveillance Study to Monitor the Safety and Efficacy of Twynsta (Telmisartan + Amlodipine SPC, q.d.) in Korean Hypertensive Patients Requiring Combination Therapy

  Boehringer Ingelheim 674 participants Est. completion 2016-08-18 1 site
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT01246193

  CKD-828(80/2.5mg) Pharmacokinetic Study

  Not yet reported Chong Kun Dang Pharmaceutical 65 participants Est. completion 2010-12 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Terminated NCT NCT01252238

  Assessment of Renin Inhibition on Insulin Sensitivity, Diastolic Function and Aortic Compliance

  Not yet reported Brigham and Women's Hospital 24 participants Est. completion 2012-12 1 site
  Other conditions: Insulin Sensitivity, Aortic Compliance, Diastolic Function
  View official trial listing →
• Completed NCT NCT01252563

  Amlodipine 10mg Drug Use Investigation

  Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 14141 participants Est. completion 2012-10
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT01256411

  A Long-term (12 Months) Safety, Tolerability and Efficacy Study of LCZ696 in Patients With Essential Hypertension

  Not yet reported Novartis Pharmaceuticals 341 participants Est. completion 2012-04 33 sites Stand-alone
  Other conditions: Essential Hypertension
  View official trial listing →
• Completed NCT NCT01264692

  Essential Hypertension

  Not yet reported Idorsia Pharmaceuticals Ltd. 196 participants Est. completion 2012-02 18 sites
  Other conditions: Essential Hypertension
  View official trial listing →
• Status unknown NCT NCT01271374

  Changes in Endothelial Function and Biomarkers in African Americans (AA) With Metabolic Syndrome

  Not yet reported InVasc Therapeutics, Inc. 80 participants Est. completion 2011-12 1 site
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT01286558

  Comparison in Japan T80/A5 (Telmisartan 80 mg and Amlodipine 5 mg) and T40/A5 (Telmisartan 40 mg and Amlodipine 5 mg)

  Not yet reported Boehringer Ingelheim 225 participants 8 sites Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT01302691

  MK-0954E Study in Participants With Hypertension (MK-0954E-357)

  Not yet reported Merck Sharp & Dohme LLC 327 participants Est. completion 2012-04-01 Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT01316419

  Twynsta Study With Lifestyle Modifications in Korean Patients With Hypertension

  Boehringer Ingelheim 2089 participants Est. completion 2014-06 55 sites
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT01337674

  Co-Administration of MK-4618 With Antihypertensive Agents (MK-4618-010)

  Not yet reported Merck Sharp & Dohme LLC 26 participants Est. completion 2011-11-01 Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT01340131

  CKD-828 (40/5mg) Pharmacokinetic Study

  Not yet reported Chong Kun Dang Pharmaceutical 68 participants Est. completion 2011-04 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT01341392

  Drug-drug Interaction Study(CKD-501, Amlodipine)

  Not yet reported Chong Kun Dang Pharmaceutical 25 participants Est. completion 2011-08 1 site Stand-alone
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT01344629

  Bioequivalence Study of Telmisartan Between Telmisartan 80 mg/Amlodipine 5 mg FDC Tablet and Telmisartan 80 mg Tab and Amlodipine 5 mg Tab Concomitant Use

  Not yet reported Boehringer Ingelheim 64 participants 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT01352689

  CKD-828(80/2.5mg) Pharmacokinetic Study_2nd

  Not yet reported Chong Kun Dang Pharmaceutical 67 participants Est. completion 2011-05 Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT01353274

  Safety and Efficacy of Daily Use of Micamlo® Combination Tablets AP in Patients With Hypertension

  Boehringer Ingelheim 1157 participants Est. completion 2013-08 254 sites
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT01354613

  Reduced Contractile Reserve: a Therapeutic Target in Heart Failure With Preserved Ejection Fraction(HFpEF)

  Not yet reported University of Wisconsin, Madison 14 participants Est. completion 2013-12 1 site Stand-alone
  Heart failure Other conditions: Pulmonary Disease, Left Ventricular Hypertrophy/Hypertension
  View official trial listing →
• Completed NCT NCT01356017

  CKD-828 Drug Interaction Study (Telmisartan)

  Not yet reported Chong Kun Dang Pharmaceutical 32 participants Est. completion 2011-09 1 site Stand-alone
  Other conditions: Healthy Male Volunteers
  View official trial listing →
• Completed NCT NCT01356043

  CKD-828 Drug Interaction Study (S-amlodipine)

  Not yet reported Chong Kun Dang Pharmaceutical 24 participants Est. completion 2011-08 1 site Stand-alone
  Other conditions: Healthy Male Volunteers
  View official trial listing →
• Terminated NCT NCT01368536

  Study to Evaluate the Efficacy and Safety of the Combination of Valturna and Amlodipine or Valturna and Chlorthalidone Versus Valturna Alone in Patients With Stage 2 Hypertension and Diabetes

  Not yet reported Novartis Pharmaceuticals 975 participants Est. completion 2012-02 97 sites Stand-alone
  Other conditions: Hypertension, Stage 2 Hypertension, Diabetes
  View official trial listing →
• Status unknown NCT NCT01394770

  Aliskiren or Amlodipine in Hypertensive Hemodialysed Patients

  Not yet reported University of Campania Luigi Vanvitelli 350 participants Est. completion 2012-09 1 site Stand-alone
  Other conditions: Hypertension, Dialysis
  View official trial listing →
• Completed NCT NCT01395199

  Amlodipine in the Prevention and Treatment of Iron Overload in Patients With Thalassemia Major

  Not yet reported University of Campinas, Brazil 62 participants Est. completion 2015-02 1 site Stand-alone
  Other conditions: Thalassemia, Iron Overload
  View official trial listing →
• Withdrawn NCT NCT01409408

  Comparison of Amlodipine and Aliskiren in Diabetic Hypertensive Patient With Blood Pressure Not Controlled by Losartan

  Not yet reported Hospital Universitario Pedro Ernesto Est. completion 2013-12 1 site
  Other conditions: Hypertension, Diabetes Mellitus
  View official trial listing →
• Terminated NCT NCT01425242

  Study on Anti-inflammatory Effect of Anti-hypertensive Treatment in Patients With Small AAA's and Mild Hypertension

  Not yet reported Amsterdam UMC, location VUmc 3 participants Est. completion 2013-12 1 site
  Other conditions: Hypertension, Abdominal Aortic Aneurysm
  View official trial listing →
• Completed NCT NCT01444885

  Evaluate the Efficacy and Safety of Pletaal (Cilostazol) in Subjects With Vasospastic Angina

  Not yet reported Korea Otsuka Pharmaceutical Co., Ltd. 50 participants Est. completion 2012-07 10 sites Stand-alone
  Other conditions: Variant Angina
  View official trial listing →
• Status unknown NCT NCT01490255

  Pharmacodynamic Effects of Ranolazine Versus Amlodipine on Platelet Reactivity

  Not yet reported University of Roma La Sapienza 100 participants Est. completion 2014-06 2 sites
  Cardiovascular disease
  View official trial listing →
• Completed NCT NCT01494727

  Phase I Study to Compare the Safety, Pharmacokinetic Profiles of CJ Amlodipine/Valsartan 10/160mg and Novartis Exforge 10/160mg

  Not yet reported HK inno.N Corporation 48 participants Est. completion 2012-04 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Status unknown NCT NCT01500590

  Effect of Renin-angiotensin System Blockers on Glomerular Filtration Rate in Patients With Hypertension, Type 2 Diabetes With Normoalbuminuria

  Not yet reported Hospital Authority, Hong Kong 1400 participants Est. completion 2019-08 1 site
  Other conditions: Diabetes, Hypertensive Disease
  View official trial listing →
• Completed NCT NCT01506011

  Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules of Dr. Reddy's Under Fasting Conditions

  Not yet reported Dr. Reddy's Laboratories Limited 50 participants Est. completion 2007-04 1 site Stand-alone
  Other conditions: Fasting
  View official trial listing →
• Completed NCT NCT01518855

  Controlled Release Nifedipine and Valsartan Combination Therapy in Patients With Essential Hypertension

  Not yet reported Bayer 514 participants Est. completion 2005-04 4 sites
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT01518998

  A Randomized, Double-Blind, Placebo-Controlled, 3x3 Factorial Design, Phase II Study to Evaluate the Antihypertensive Efficacy and Safety of Combination of Fimasartan and Amlodipine in Patients With Essential Hypertension

  Not yet reported Boryung Pharmaceutical Co., Ltd 420 participants Est. completion 2013-11 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Withdrawn NCT NCT01549496

  A Drug Interaction Study of Boceprevir in Combination With Amlodipine or Diltiazem in Healthy Volunteers

  Not yet reported Ottawa Hospital Research Institute 1 site Stand-alone
  Other conditions: Hepatitis C, Hypertension
  View official trial listing →
• Completed NCT NCT01556997

  Perindopril Amlodipine for the Treatment of Hypertension

  Not yet reported Symplmed Pharmaceuticals LLC 837 participants Est. completion 2013-02 48 sites Stand-alone
  Other conditions: Essential Hypertension
  View official trial listing →
• Status unknown NCT NCT01557153

  Vascular Augmentation of Late-life Unremitted Depression (VALUeD)

  Not yet reported Gateshead Health NHS Foundation Trust 80 participants Est. completion 2014-04 1 site Stand-alone
  Other conditions: Depression
  View official trial listing →
• Status unknown NCT NCT01567774

  Pharmacodynamic Effects of Atorvastatin vs. Rosuvastatin on Platelet Reactivity

  Not yet reported University of Roma La Sapienza 100 participants Est. completion 2015-06 2 sites
  Cardiovascular disease
  View official trial listing →
• Completed NCT NCT01603940

  Comparison Between Losartan and Benazepril in Diabetic Hypertensive Patients Not Controlled by Amlodipine

  Not yet reported Hospital Universitario Pedro Ernesto 30 participants Est. completion 2015-01 1 site
  Other conditions: Hypertension, Diabetes Mellitus
  View official trial listing →
• Completed NCT NCT01611077

  Efficacy and Safety of a Therapy Change From Candesartan 32 mg to Fixed Combination of Olmesartan 40 mg/Amlodipine 10 mg

  Not yet reported Institut für Pharmakologie und Präventive Medizin 88 participants Est. completion 2013-01 11 sites
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT01613209

  Sevicontrol-1: Efficacy and Safety of a Fixed Combination of Olmesartan/ Amlodipine

  Not yet reported Institut für Pharmakologie und Präventive Medizin 83 participants Est. completion 2012-10 12 sites Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Withdrawn NCT NCT01631409

  Estimation of the Long Term Effectiveness of Routine Use of Cardiac Shock Wave Therapy

  City Hospital No 40, Saint Petersburg, Russia Est. completion 2021-09
  Other conditions: Coronary Heart Disease (CHD)
  View official trial listing →
• Completed NCT NCT01634295

  Efficacy and Safety of CKD-828 to Stage 2 Hypertension

  Not yet reported Chong Kun Dang Pharmaceutical 103 participants Est. completion 2013-05 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT01648231

  Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Amlodipine and Losartan in Health Volunteers

  Not yet reported GlaxoSmithKline 23 participants Est. completion 2012-09-25 1 site
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT01658657

  A Pilot Study of Plasma Renin Activity Guided vs Generic Combination Therapy for Hypertension

  Not yet reported University of North Carolina, Chapel Hill 17 participants Est. completion 2014-07 1 site Stand-alone
  Other conditions: Hypertension, Plasma Renin Activity
  View official trial listing →
• Status unknown NCT NCT01665235

  Blood Pressure Variability and the Prognosis of Ischemic Stroke With Intracranial Artery Stenosis

  Not yet reported RenJi Hospital 200 participants Est. completion 2014-08 1 site
  Other conditions: Blood Pressure Variability, Intracranial Artery Stenosis
  View official trial listing →
• Completed NCT NCT01713647

  Bioequivalence Study of Amlodipine / Losartan/ Hydrochlorothiazide of PHARMALINE, Lebanon Under Fastion Conditions

  Not yet reported Pharmaceutical Research Unit, Jordan 39 participants Est. completion 2012-12 1 site Stand-alone
  Other conditions: Fasting
  View official trial listing →
• Completed NCT NCT01713920

  Efficacy and Tolerability of Combination Antihypertensive Drug in Non-Responders to ARB monoTHerapy Using 24h ABPM

  Not yet reported Sang Hyun Ihm, MD PhD 68 participants Est. completion 2014-09 2 sites
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT01735890

  Phase Ⅰ Study to Compare the Safety, Pharmacokinetic Profiles of CJ Amlodipine/Valsartan 10/160mg Tablet and Novartis Exforge 10/160mg Tablet

  Not yet reported HK inno.N Corporation 48 participants Est. completion 2012-11 Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT01738945

  Effect of Calcium Channel Blocker on the Serum Fibrobalst Growth Factor-23 (FGF-23) Levels in Type-2 Diabetic Patients With Proteinuria Purpose

  Not yet reported Gulhane School of Medicine 32 participants Est. completion 2009-05 1 site
  Other conditions: We Searched for the Effects of Calcium Channel Blocker Amlodipine on the Clinical and Laboratory Parameters of Diabetic Patients With Proteinuria.
  View official trial listing →
• Completed NCT NCT01762501

  Azilsartan Circadian and Sleep Pressure

  Not yet reported Sogo Rinsho Médéfi Co., Ltd. 957 participants Est. completion 2013-12 92 sites
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT01797926

  Study to Determine the Bioequivalence of Two Fixed Dose Combination (FDC) Tablet Formulations of Amlodipine and Losartan FDC5/50 and FDC5/100 Under Fasting Conditions

  Not yet reported GlaxoSmithKline 102 participants Est. completion 2013-07-25 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT01819220

  Randomized, Open Labeled Clinical Trial to Compare the Effectiveness of Amlodipine/Valsartan vs Hydrochlorothiazide/Telmisartan on Glucose Tolerance in Patients With Hypertension With Metabolic Syndrome

  Not yet reported Yonsei University 16 participants Est. completion 2014-11 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT01819779

  Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects (N=60)

  Not yet reported Hanlim Pharm. Co., Ltd. 53 participants Est. completion 2013-11 1 site Stand-alone
  Other conditions: Healthy Male Subjects
  View official trial listing →
• Completed NCT NCT01823913

  Safety and Pharmacokinetic Comparison of Exforge® and G-0081 in Healthy Male Volunteers

  Not yet reported Severance Hospital 50 participants Est. completion 2012-09 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT01828359

  The Efficacy and Safety Study of Anti-hypertension Combination Drug in Patients Uncontrolled With Monotherapy.

  Not yet reported Hanmi Pharmaceutical Company Limited 199 participants Est. completion 2013-01 Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT01830517

  Diurnal Variation in Hypertensive Stroke Patients

  Not yet reported Hanmi Pharmaceutical Company Limited 84 participants Est. completion 2012-02 1 site Stand-alone
  Cardiovascular disease Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT01842230

  Study to Investigate the Effect of Atorvastatin on the Pharmacokinetic Properties of Telmisartan/S-amlodipine

  Not yet reported Chong Kun Dang Pharmaceutical 24 participants Est. completion 2013-07 1 site Stand-alone
  Other conditions: Essential Hypertension, Hyperlipidemia
  View official trial listing →
• Status unknown NCT NCT01844570

  Levamlodipine Maleate or Amlodipine Besylate for Treatment of Hypertension: A Comparative Effectiveness Research

  Peking University First Hospital 10000 participants Est. completion 2015-12 1 site
  Other conditions: Primary Hypertension
  View official trial listing →
• Status unknown NCT NCT01845272

  Pharmacokinetic Interactions of Candesartan Cilexetil and Amlodipine Besylate

  Not yet reported HK inno.N Corporation 40 participants Est. completion 2013-08 Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Status unknown NCT NCT01848873

  Efficacy of Amlodipine-folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine

  Not yet reported, Not yet reported Shenzhen Ausa Pharmed Co.,Ltd 756 participants Est. completion 2013-08 16 sites Stand-alone
  Other conditions: Essential Hypertension
  View official trial listing →
• Withdrawn NCT NCT01865188

  Study of the Efficacy and Safety of LCZ696 Alone and in Combination With Amlodipine in Patients With Hypertension

  Not yet reported Novartis Pharmaceuticals Est. completion 2015-04 Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT01896661

  Effect of Antihypertensive Agents Over Sleep Apnea

  Not yet reported Hospital de Clinicas de Porto Alegre 53 participants Est. completion 2016-02 1 site
  Obstructive sleep apnea Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT01911780

  Compare Efficacy and Safety of Telmisartan/Hydrochlorothiazide With Telmisartan/Hydrochlorothiazide Plus Amlodipine

  Not yet reported Boehringer Ingelheim 132 participants Est. completion 2015-01 17 sites Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Status unknown NCT NCT01922687

  Amlodipine Plus/Minus Atorvastatin for Protection of Arteries

  Not yet reported Shanghai Institute of Hypertension 109 participants Est. completion 2014-12 1 site Stand-alone
  Other conditions: Arterial and Arteriolar Disorders
  View official trial listing →
• Completed NCT NCT01926652

  Safety and Pharmacokinetics Study of Amlodipine 10mg and Candesartan 32mg

  Not yet reported Shin Poong Pharmaceutical Co. Ltd. 34 participants Est. completion 2013-08 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Status unknown NCT NCT01956786

  Efficacy of Amlodipine-Folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine

  Not yet reported, Not yet reported Shenzhen Ausa Pharmed Co.,Ltd 540 participants Est. completion 2014-02 3 sites Stand-alone
  Other conditions: Essential Hypertension
  View official trial listing →
• Completed NCT NCT01964079

  Comparision of Blood Pressure Variability Between Amlodipine and Losartan

  Not yet reported Wonju Severance Christian Hospital 144 participants Est. completion 2017-05 1 site
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT01975246

  Add-on to Micamlo BP Trial

  Not yet reported Boehringer Ingelheim 309 participants Est. completion 2014-07 30 sites Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT01977794

  Fixed Dose Combination of Bisoprolol and Amlodipine in the Treatment of Hypertension

  Not yet reported Merck KGaA, Darmstadt, Germany 200 participants Est. completion 2015-03 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Status unknown NCT NCT01983735

  Efficacy and Safety of TELMINUVO to Stage 2 Hypertension

  Not yet reported Chong Kun Dang Pharmaceutical 200 participants Est. completion 2014-08 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT01984164

  CAndesartan vs LIsinopril Effects on the BRain

  Not yet reported Emory University 176 participants Est. completion 2018-12-03 1 site
  Other conditions: Hypertension, Mild Cognitive Impairment
  View official trial listing →
• Terminated NCT NCT01994408

  Default BP Medication Intensification

  Not yet reported, Not yet reported Cedars-Sinai Medical Center 3 participants Est. completion 2015-12 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT01996085

  Non-invasive Haemodynamic Assessment in Hypertension

  Not yet reported Military Institute od Medicine National Research Institute 144 participants Est. completion 2017-12 1 site Stand-alone
  Other conditions: Arterial Hypertension
  View official trial listing →
• Completed NCT NCT02034435

  Endogenous Renin-Angiotensin-Aldosterone System and Glucose Metabolism

  Not yet reported Vanderbilt University Medical Center 44 participants Est. completion 2019-12 1 site
  Metabolic syndrome
  View official trial listing →
• Completed NCT NCT02046395

  Effect of Renin-angiotensin-system Blockade on Urinary Free Light Chains in Patients With Type 2 Diabetes Mellitus

  Not yet reported Tulane University School of Medicine 28 participants Est. completion 2019-12 1 site
  Type 2 diabetes Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT02047175

  CKD-346 DDI Study(Telmisartan/S-Amlodipine, Rosuvastatin)

  Not yet reported Chong Kun Dang Pharmaceutical 64 participants Est. completion 2014-03 1 site Stand-alone
  Other conditions: Hypertension, Hyperlipidemia
  View official trial listing →
• Completed NCT NCT02058446

  PMS Study of Amlodipine/Valsartan for the Treatment of Hypertension

  Not yet reported TSH Biopharm Corporation Limited 36 participants Est. completion 2014-03 1 site Stand-alone
  Other conditions: Essential Hypertension
  View official trial listing →
• Terminated NCT NCT02058823

  Intermittent Hypoxia 2: Cardiovascular and Metabolism

  Not yet reported University Hospital, Grenoble 12 participants Est. completion 2017-03-16 1 site
  Obstructive sleep apnea Other conditions: Hypoxia, Sleep Apnea
  View official trial listing →
• Status unknown NCT NCT02059616

  A Phase 2 Dose Selection Trial of Candesartan Cilexetil and Amlodipine Besylate to Treat Essential Hypertension

  Not yet reported HK inno.N Corporation 384 participants Est. completion 2015-12 20 sites Stand-alone
  Other conditions: Essential Hypertension
  View official trial listing →
• Completed NCT NCT02060019

  Pharmacokinetic Interactions and Safety Between Exforge Tab. and Crestor Tab. in Healthy Male Subjects

  Not yet reported HK inno.N Corporation 57 participants Est. completion 2014-12 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT02064556

  CKD-330 Drug-Drug Interaction Study (Amlodipine)

  Not yet reported Chong Kun Dang Pharmaceutical 24 participants Est. completion 2014-07 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT02064621

  CKD-330 Drug-Drug Interaction Study (Candesartan)

  Not yet reported Chong Kun Dang Pharmaceutical 24 participants Est. completion 2014-08 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT02065492

  Amlodipine for Myocardial Iron in Thalassemia

  Not yet reported, Not yet reported Aga Khan University 20 participants Est. completion 2015-11 1 site Stand-alone
  Other conditions: Thalassemia
  View official trial listing →
• Completed NCT NCT02069821

  Pharmacokinetic Interactions Between Amlodipine Besylate/Valsartan and Atorvastatin in Healthy Male Subjects

  Not yet reported HK inno.N Corporation 56 participants Est. completion 2014-07 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT02072330

  Study to Evaluate the Efficacy and Safety of Combined Administration of TAK-536CCB and Hydrochlorothiazide in Patients With Grade I or II Essential Hypertension.

  Not yet reported, Not yet reported Takeda 353 participants Est. completion 2013-12 13 sites
  Other conditions: Grade I or II Essential Hypertension
  View official trial listing →
• Completed NCT NCT02089399

  Pharmacokinetics and Drug Interaction Study Between Amlodipine,Olmesartan and Rosuvastatin in Healthy Adult Volunteers

  Not yet reported Daewoong Pharmaceutical Co. LTD. 32 participants Est. completion 2014-06 1 site
  Other conditions: Healthy
  View official trial listing →
• Active, not recruiting NCT NCT02099123

  A Clinical Trial of STAtin Therapy for Reducing Events in the Elderly (STAREE)

  Not yet reported Monash University 9971 participants Est. completion 2025-12 6 sites
  Other conditions: Independent Living, Disability Free Survival, Elderly, Healthy
  View official trial listing →
• Completed NCT NCT02121041

  Ambulatory vs Office BP Management Usual Care for Diagnosing and Managing Hypertension: A Pilot Study

  Not yet reported Anthony J Viera, MD, MPH 28 participants Est. completion 2016-07 1 site
  Other conditions: Hypertension
  View official trial listing →
• Status unknown NCT NCT02128386

  Medication Adherence and "True" Resistance in Patients With Resistant Hypertension

  Charite University, Berlin, Germany 50 participants Est. completion 2016-03 1 site
  Other conditions: Hypertensive Disease, Hypertension, Resistant to Conventional Therapy
  View official trial listing →
• Completed NCT NCT02129192

  Bioequivalence Study of Telmisartan Between Telmisartan 80 mg/Amlodipine 5 mg/Hydrochlorothiazide 12.5 mg (T80/A5/H12.5 mg) Fixed-dose Combination (FDC) Tablet and T80/H12.5 mg Tab and A5 mg (Encap A2.5 mg Tab x2) Concomitant Use

  Not yet reported Boehringer Ingelheim 72 participants Est. completion 2014-09 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT02130687

  Effect of Chronic ACE and DPP4 Inhibition on Blood Pressure

  Not yet reported Vanderbilt University 106 participants Est. completion 2020-08 1 site
  Type 2 diabetes Other conditions: Hypertension
  View official trial listing →
• Status unknown NCT NCT02140489

  Evaluating a Pharmacokinetic Drug Interaction Between Amlodipine/Losartan and Rosuvastatin

  Not yet reported Hanmi Pharmaceutical Company Limited 30 participants Est. completion 2014-08 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT02152969

  Drug-drug Interaction Study (Telmisartan, Amlodipine, Chlorthalidone)

  Not yet reported Yuhan Corporation 66 participants Est. completion 2014-11 1 site
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT02166398

  A Randomized, Open-label, Single Dose, Two-way Crossover Clinical Trial to Compare the Safety, Pharmacokinetic Profiles of UI15AML055MT and Amosartan® Tablet 5/50 mg After a Single Oral Administration in Healthy Male Volunteers

  Not yet reported Korea United Pharm. Inc. 46 participants Est. completion 2014-12 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT02172040

  Study to Evaluate the Effect of Celecoxib on the Efficacy and Safety of Amlodipine in Subjects With Hypertension Requiring Antihypertensive Therapy

  Not yet reported Kitov Pharmaceuticals, Ltd. 152 participants Est. completion 2015-11-19 10 sites Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT02177409

  Telmisartan Versus Amlodipine in Patients With Mild-to-Moderate Hypertension

  Not yet reported Boehringer Ingelheim 431 participants
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT02183675

  Pharmacokinetics of Different Formulations of Telmisartan, Amlodipine, and Hydrochlorothiazide (HCTZ) in Japanese Healthy Male Volunteers

  Not yet reported Boehringer Ingelheim 36 participants Est. completion 2014-10 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT02186496

  Bioequivalence Study (Candesartan 8 mg and Amlodipine 5 mg)

  Not yet reported Chong Kun Dang Pharmaceutical 32 participants Est. completion 2014-11 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT02193308

  Bioequivalence of Telmisartan/Amlodipine Fixed Dose Combination Compared With Its Monocomponents in Healthy Male and Female Volunteers

  Not yet reported Boehringer Ingelheim 84 participants Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT02205151

  To Compare the Pharmacokinetics of Fimasartan/Amlodipine Combination Tablet and Coadministration of Fimasartan and Amlodipine as Individual Tablets

  Not yet reported Boryung Pharmaceutical Co., Ltd 86 participants Est. completion 2014-09 1 site
  Other conditions: Hypertension
  View official trial listing →
• Status unknown NCT NCT02206165

  A Dose Selection Trial of CKD-330 in Patients With Essential Hypertension

  Not yet reported Chong Kun Dang Pharmaceutical 456 participants Est. completion 2015-06 1 site Stand-alone
  Other conditions: Essential Hypertension
  View official trial listing →
• Completed NCT NCT02231788

  The Efficacy of a Combination of Telmisartan/S-Amlodipine Compared With Telmisartan Monotherapy

  Not yet reported Chong Kun Dang Pharmaceutical 217 participants Est. completion 2018-03 11 sites Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Terminated NCT NCT02232880

  Treatment of Resistant Hypertension by Prevention of T-Cell Co-Stimulation

  Not yet reported Vanderbilt University Medical Center 1 participants Est. completion 2015-06 1 site
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT02250833

  CKD-828 (80/5mg) Pharmacokinetic Study

  Not yet reported Chong Kun Dang Pharmaceutical 69 participants Est. completion 2014-12 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT02259777

  Bioavailability of Telmisartan/Amlodipine Fixed Dose Combination in Healthy Male and Female Volunteers

  Not yet reported Boehringer Ingelheim 40 participants Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT02259803

  Relative Bioavailability of Telmisartan/Amlodipine Fixed-dose Combination Compared to Its Mono-components in Healthy Male Volunteers

  Not yet reported Boehringer Ingelheim 30 participants Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT02259816

  Pharmacokinetics of Telmisartan Alone and in Combination With Amlodipine in Healthy Volunteers

  Not yet reported Boehringer Ingelheim 38 participants Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT02259829

  Bioequivalence Study of Telmisartan/Amlodipine Fixed Dose Combination Compared With Its Monocomponents in Healthy Male and Female Volunteers

  Not yet reported Boehringer Ingelheim 84 participants Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT02261064

  Influence of Food on the Bioavailability of Telmisartan/Amlodipine Fixed Dose Combination in Healthy Japanese Male Volunteers

  Not yet reported Boehringer Ingelheim 32 participants Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT02277691

  A Phase III Long-term Study of TAK-536TCH in Participants With Essential Hypertension

  Not yet reported Takeda 341 participants Est. completion 2016-04-25 38 sites
  Other conditions: Essential Hypertension
  View official trial listing →
• Completed NCT NCT02278471

  The SCCS Polypill Pilot Trial

  Not yet reported Vanderbilt University 303 participants Est. completion 2018-06-27 1 site Stand-alone
  Other conditions: Hypertension, Hyperlipidemia
  View official trial listing →
• Completed NCT NCT02292069

  Bioavailability Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80 mg Under Fed Condition

  Not yet reported Dr. Reddy's Laboratories Limited 90 participants Est. completion 2011-10 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT02295046

  Bioavailability Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80 mg Under Fasting Condition

  Not yet reported Dr. Reddy's Laboratories Limited 80 participants Est. completion 2011-11 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT02353806

  Pharmacokinetics of Amlodipine Besylate at Delivery and During Lactation

  Not yet reported University of Texas Southwestern Medical Center 16 participants Est. completion 2016-09 1 site Stand-alone
  Other conditions: Chronic Hypertension in Pregnancy
  View official trial listing →
• Completed NCT NCT02358824

  CKD-828 (80/5mg) Pharmacokinetic Study

  Not yet reported Chong Kun Dang Pharmaceutical 48 participants Est. completion 2015-06 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT02364089

  Surgery of Subclinical Cortisol Secreting Adrenal Incidentalomas

  Not yet reported University Hospital, Bordeaux 78 participants Est. completion 2022-11-23 17 sites
  Other conditions: Adrenal Incidentalomas
  View official trial listing →
• Completed NCT NCT02368652

  A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Candesartan Cilexetil Monotherapy

  Not yet reported HK inno.N Corporation 181 participants Est. completion 2015-11 19 sites Stand-alone
  Other conditions: Essential Hypertension
  View official trial listing →
• Completed NCT NCT02368665

  A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Amlodipine Besylate Monotherapy

  Not yet reported HK inno.N Corporation 180 participants Est. completion 2016-11 19 sites Stand-alone
  Other conditions: Essential Hypertension
  View official trial listing →
• Completed NCT NCT02373163

  INTERVENCION Trial

  Not yet reported Prevencion 166 participants Est. completion 2016-06-01 1 site
  Other conditions: Blood Pressure, High
  View official trial listing →
• Completed NCT NCT02377661

  Lowering Blood Pressure in Primary Care in Vienna

  Not yet reported Wilhelminenspital Vienna 229 participants Est. completion 2017-05-30 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT02378064

  Comparison of Fimasartan Versus Amlodipine Therapy on Carotid PlaquE Inflammation

  Not yet reported CHEOL WHAN LEE, M.D., Ph.D 50 participants Est. completion 2017-12 1 site
  Other conditions: Inflammation Plaque, Atherosclerotic, Coronary Disease, Renin-Angiotensin System
  View official trial listing →
• Completed NCT NCT02387554

  Pharmacokinetic Interaction Between HGP0904, HGP0608 and HGP1405

  Not yet reported Hanmi Pharmaceutical Company Limited 33 participants Est. completion 2014-10 1 site Stand-alone
  Other conditions: Hypertension(HTN)
  View official trial listing →
• Completed NCT NCT02387619

  The Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan/Amlodipine

  Not yet reported Jeil Pharmaceutical Co., Ltd. 41 participants Est. completion 2015-07 1 site Stand-alone
  Other conditions: Hypertension, Hyperlipidemia
  View official trial listing →
• Completed NCT NCT02397538

  Study to Evaluate the Pharmacokinetic Interaction and Safety After Multiple Oral Doses of Fimasartan/Amlodipine and Rosuvastatin in Healthy Male Subjects

  Not yet reported Boryung Pharmaceutical Co., Ltd 50 participants Est. completion 2015-04 1 site
  Other conditions: Hypertension
  View official trial listing →
• Status unknown NCT NCT02408172

  Effects of Metoprolol and Amlodipine on Cardiac Remodeling, Arrhythmias and Blood Pressure Variation in Hypertensive Patients With Sleep Apnea Syndrome

  Not yet reported, Not yet reported First Affiliated Hospital of Harbin Medical University 20 participants Est. completion 2017-12 2 sites Stand-alone
  Other conditions: Sleep Apnea Syndrome, Hypertension
  View official trial listing →
• Status unknown NCT NCT02415192

  Observational Study to Evaluate the Safety and Efficacy for Levacalm Tab. Versus Valsartan/Amlodipine Combination Therapy in Essential Hypertension Patients

  LG Life Sciences 2001 participants Est. completion 2016-11 1 site
  Other conditions: Lower Leg Edema, Orthostatic Hypertension
  View official trial listing →
• Status unknown NCT NCT02474420

  Amlodipine as Adjuvant Treatment to Iron Chelation for Prevention of Cardiac Iron Overload in Thalassemia Patients

  Not yet reported Kevin H.M. Kuo, MD, MSc, FRCPC 60 participants Est. completion 2018-06 1 site Stand-alone
  Other conditions: Beta-Thalassemia, Iron Overload
  View official trial listing →
• Completed NCT NCT02496910

  PK Study of YH22162 FDC Compared to Combination of Twynsta and Hygroton

  Not yet reported Yuhan Corporation 180 participants Est. completion 2015-09 1 site
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT02504606

  Safety and Pharmacokinetics of Besylsartan Tablet in Healthy Male Subject

  Not yet reported Huons Co., Ltd. 60 participants Est. completion 2014-10 Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT02519010

  A Bioequivalence Study of Amlodipine / Valsartan From Amlodipine/Valsartan 10/160 Tablets (Pharmacare, Palestine) and Exforge Tablets (Novartis Pharma, USA)

  Not yet reported Genuine Research Center, Egypt 36 participants Est. completion 2011-03 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Status unknown NCT NCT02526875

  Efficacy of a Telmisartan/S-Amlodipine on 24-hour BP Control in Hypertensive Patients Inadequately Controlled

  Not yet reported Chong Kun Dang Pharmaceutical 208 participants Est. completion 2017-11 10 sites
  Other conditions: Hypertension
  View official trial listing →
• Terminated NCT NCT02539810

  Renal Artery Stenting in Patients With Documented Resistant Hypertension and Atherosclerotic Renal Artery Stenosis (ANDORRA)

  Not yet reported Assistance Publique - Hôpitaux de Paris 4 participants Est. completion 2017-07 15 sites Stand-alone
  Other conditions: Hypertension, Hypertension Resistant to Conventional Therapy, Angiographically Proven Grade III Unilateral or Bilateral Atherosclerotic Renal Artery Stenosis (ARAS) Greater Than or Equal to 60 Percent
  View official trial listing →
• Completed NCT NCT02548286

  Study to Compare the Safety and Pharmacokinetics of CKD-330 8/5mg With Coadministration of the Two Separate Drugs

  Not yet reported Chong Kun Dang Pharmaceutical 53 participants Est. completion 2015-09 1 site
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT02569814

  A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin

  Not yet reported Boryung Pharmaceutical Co., Ltd 100 participants Est. completion 2015-12 1 site
  Other conditions: Hypertension, Hyperlipidemia
  View official trial listing →
• Completed NCT NCT02586311

  CKD-330 Phase 3 Trial in Amlodipine Non-responder

  Not yet reported Chong Kun Dang Pharmaceutical 160 participants Est. completion 2016-09 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Terminated NCT NCT02608242

  PK Study of YH22189 FDC Compared to Combination of Telmisartan/Amlodipine and Rosuvastatin

  Not yet reported Yuhan Corporation 123 participants Est. completion 2016-06 1 site
  Other conditions: Hypertension, Hyperlipidemia
  View official trial listing →
• Completed NCT NCT02620163

  Efficacy & Safety Study of YH22162 vs Telmisartan/Amlodipine in Patients With Hypertension Inappropriately Controlled on Telmisartan/Amlodipine Treatment

  Not yet reported Yuhan Corporation 381 participants Est. completion 2016-12 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Status unknown NCT NCT02665832

  Study of DWJ1351 in Healthy Male Volunteers

  Not yet reported Daewoong Pharmaceutical Co. LTD. 58 participants Est. completion 2016-06 Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT02699645

  Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial

  Not yet reported The George Institute 1671 participants Est. completion 2025-08-27 58 sites Stand-alone
  Other conditions: Intracerebral Haemorrhage (ICH), Hypertension
  View official trial listing →
• Completed NCT NCT02707913

  Clinical Bioequivalence Study on Two Amlodipine Tablet 10mg Formulations

  Not yet reported Bright Future Pharmaceuticals Factory O/B Bright Future Pharmaceutical Laboratories Limited 17 participants Est. completion 2016-09 Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Status unknown NCT NCT02710539

  Once-daily Fixed Combination of Three Antihypertensive Drugs

  Not yet reported University of Roma La Sapienza 100 participants Est. completion 2020-03 1 site
  Other conditions: Arterial Hypertension
  View official trial listing →
• Completed NCT NCT02734355

  Left Atrial Mechanical Function Improvement After Atrial Fibrillation Catheter Ablation

  Not yet reported Research Institute for Complex Problems of Cardiovascular Diseases, Russia 64 participants Est. completion 2016-02
  Other conditions: Atrial Fibrillation
  View official trial listing →
• Completed NCT NCT02739672

  Clinical Trial to Compare the Pharmacokinetics of TAH Tablet in Comparison to the Co-administration of Telmisartan, Amlodipine and Hydrochlorothiazide in Healthy Male Volunteers

  Not yet reported IlDong Pharmaceutical Co Ltd 40 participants Est. completion 2016-04-06 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT02742467

  Comparison of Three Combination Therapies in Lowering Blood Pressure in Black Africans

  Not yet reported University of Abuja 702 participants Est. completion 2018-06-01 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT02774460

  The Precision Hypertension Care Study

  Not yet reported Uppsala University 280 participants Est. completion 2021-06-11 1 site
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT02801526

  Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - A

  Not yet reported Chong Kun Dang Pharmaceutical 32 participants Est. completion 2015-08 Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT02811731

  Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - B

  Not yet reported Chong Kun Dang Pharmaceutical 32 participants Est. completion 2015-08 Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Status unknown NCT NCT02814500

  DP-R212 Pharmacokinetic Study Phase I

  Not yet reported Alvogen Korea 36 participants Est. completion 2016-09 Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Status unknown NCT NCT02817503

  Feasibility Study of the Intensive Systolic Blood Pressure Control

  Not yet reported Second Affiliated Hospital of Nanchang University 100 participants Est. completion 2016-12 1 site Stand-alone
  Other conditions: Hypertension, Hyperhomocysteinemia
  View official trial listing →
• Completed NCT NCT02834403

  L-NMMA Plus Taxane Chemotherapy in Refractory Locally Advanced or Metastatic Triple Negative Breast Cancer Patients

  Not yet reported, Not yet reported The Methodist Hospital Research Institute 37 participants Est. completion 2021-01 1 site Stand-alone
  Other conditions: Metastatic Triple Negative Breast Cancer
  View official trial listing →
• Completed NCT NCT02847338

  Comparison of Optimal Hypertension Regimens

  Not yet reported Cambridge University Hospitals NHS Foundation Trust 940 participants Est. completion 2023-10 14 sites Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Terminated NCT NCT02850081

  Statin Neuroprotection and Carotid Endarterectomy: Safety, Feasibility and Outcomes

  Not yet reported Columbia University 31 participants Est. completion 2020-03-31 7 sites Stand-alone
  Cardiovascular disease Other conditions: Carotid Artery Stenosis
  View official trial listing →
• Status unknown NCT NCT02900729

  Randomized Controlled Trial of Renal Denervation for Resistant Hypertension

  Not yet reported Shanghai WiseGain Medical Devices Co., Ltd. 254 participants Est. completion 2018-02 13 sites Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT02913664

  Risk Reduction for Alzheimer's Disease

  Not yet reported, Not yet reported University of Texas Southwestern Medical Center 513 participants Est. completion 2022-01-31 4 sites Stand-alone
  Other conditions: Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline, Family History of Alzheimer's Disease
  View official trial listing →
• Completed NCT NCT02916602

  A Study to Evaluate Efficacy and Safety of HCP1401 for Stage 2 Hypertension Patients Not Controlled by HCP0605

  Not yet reported Hanmi Pharmaceutical Company Limited 340 participants Est. completion 2016-09 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT02920047

  A Clinical Trial to Evaluate the Pharmacokinetics and Safety of Fimasartan and Amlodipine in Healthy Male Subjects

  Not yet reported Boryung Pharmaceutical Co., Ltd 60 participants Est. completion 2017-01 Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT02933658

  Study of Multiple Oral Dosing to Evaluate the Safety and the Pharmacokinetic Drug-drug Interaction of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers

  Not yet reported Daewon Pharmaceutical Co., Ltd. 71 participants Stand-alone
  Other conditions: Hypertension and Dyslipidemia
  View official trial listing →
• Terminated NCT NCT02940548

  Nifedipine GITS and Amlodipine Besylate on Recovery of Blood Pressure Rhythm and Arterial Stiffness

  Not yet reported Jing Liu 99 participants Est. completion 2020-12 1 site
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT02944734

  Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential Hypertension

  Not yet reported Shin Poong Pharmaceutical Co. Ltd. 392 participants Est. completion 2015-12 23 sites Stand-alone
  Other conditions: Essential Hypertension
  View official trial listing →
• Completed NCT NCT02951962

  A Study to Investigate Pharmacokinetic Drug Interaction and Safety of Telmisartan/Amlodipine and Rosuvastatin

  Not yet reported Yuhan Corporation 60 participants Est. completion 2016-09 1 site
  Other conditions: Hypertension, Hyperlipidemia
  View official trial listing →
• Completed NCT NCT02962258

  BE Study of Torrent's Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Tab - Fed Conditions

  Not yet reported Torrent Pharmaceuticals Limited 34 participants Est. completion 2011-06 Stand-alone
  Other conditions: Healthy Subjects
  View official trial listing →
• Completed NCT NCT02962336

  Bioequivalence Study of Torrent's Olmesartan Medoxomil, Amlodipine and Hydrochloride Tablets Under Fasting Conditions.

  Not yet reported Torrent Pharmaceuticals Limited 34 participants Est. completion 2011-06 Stand-alone
  Other conditions: Healthy Subjects
  View official trial listing →
• Status unknown NCT NCT02966717

  Rituximab Combined With MSCs in the Treatment of PNS (3-4 Stage of CKD)

  Not yet reported Zhujiang Hospital 116 participants Est. completion 2021-10 1 site
  Other conditions: Renal Insufficiency, Chronic, Nephrotic Syndrome
  View official trial listing →
• Completed NCT NCT02974439

  Bioequivalence Study of Amlodipine and Norvasc Under Fasting and FED Conditions in Chinese Healthy Volunteers

  Not yet reported Shanghai Haini Pharmaceutical Co., Ltd. 60 participants Est. completion 2017-03-21 1 site Stand-alone
  Other conditions: Bioequivalence
  View official trial listing →
• Completed NCT NCT02979197

  Evaluation of Celecoxib Effects on Amlodipine in Subjects With Existing Hypertension Requiring Antihypertensives

  Not yet reported Kitov Pharma Ltd 105 participants Est. completion 2017-07-21 9 sites Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT02988362

  Bioequivalence Study (Candesartan 16 mg and Amlodipine 10 mg)

  Not yet reported HanAll BioPharma Co., Ltd. 42 participants Est. completion 2017-02-04 Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT02995720

  A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin

  Not yet reported Boryung Pharmaceutical Co., Ltd 60 participants Est. completion 2017-05-30 Stand-alone
  Other conditions: Hypertension, Hyperlipidemia
  View official trial listing →
• Status unknown NCT NCT02996916

  Efficacy of Olmesartan on Cerebral Glucose Metabolism, Vascular Inflammation and Adipose Tissue

  Not yet reported Kurume University 100 participants Est. completion 2020-12 1 site
  Other conditions: Efficacy of Olmesartan on Cerebral Glucose Metabolism in Essential Hypertension
  View official trial listing →
• Completed NCT NCT03009474

  Pharmacokinetics Study of CJ-30060 After Single Dose Administration in Health Male Volunteers

  Not yet reported HK inno.N Corporation 52 participants Est. completion 2015-04 1 site Stand-alone
  Other conditions: Hypertension, Hyperlipidemias
  View official trial listing →
• Completed NCT NCT03021265

  To Evaluate Real-world Safety, Effectiveness and Appropriate Use of Micatrio® Combination Tablets Treatment in Patients With Hypertension

  Boehringer Ingelheim 676 participants Est. completion 2019-04-11 1 site
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT03024476

  Optimization of Blood Pressure Management After Acute Ischemic Stroke and Its Prognostic Significance

  Not yet reported Seoul National University Bundang Hospital 67 participants Est. completion 2017-12-07 3 sites Stand-alone
  Cardiovascular disease Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT03032315

  Compare the Pharmacokinetics of TAH(80/10/12.5) Tablet in Comparison to the Co-administration of Telmisartan, Amlodipine and Hydrochlorothiazide in Healthy Male Volunteers

  Not yet reported IlDong Pharmaceutical Co Ltd 44 participants Est. completion 2016-12-27 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT03038451

  Efficacy and Safety of S-amlodipine 2,5 mg and 5 mg in Hypertension Patients

  Not yet reported Neutec Ar-Ge San ve Tic A.Ş 43 participants Est. completion 2017-02-14 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Withdrawn NCT NCT03047538

  Fixed Combination for Lipid and Blood Pressure Control

  Not yet reported Charles University, Czech Republic Est. completion 2019-12-31 1 site
  Other conditions: Arterial Hypertension, Dyslipidemias, Blood Pressure, Lipid Metabolism Disorders
  View official trial listing →
• Status unknown NCT NCT03054467

  Effect of Amlodipine Versus Amlodipine Combined With Atorvastatin on the Coronary Vasospastic Angina

  Not yet reported Kosin University Gospel Hospital 150 participants Est. completion 2019-04-28
  Other conditions: Quality of Life
  View official trial listing →
• Terminated NCT NCT03082014

  Effects of Amlodipine and Other Blood Pressure Lowering Agents on Microvascular Function

  Not yet reported Ludwig-Maximilians - University of Munich 101 participants Est. completion 2022-07-28 5 sites
  Other conditions: Cerebral Small Vessel Diseases
  View official trial listing →
• Completed NCT NCT03088254

  Study to Evaluate the Efficacy and Safety of Telmisartan/Amlodipine/Rosuvastatin

  Not yet reported Jeil Pharmaceutical Co., Ltd. 126 participants Est. completion 2017-12-04 12 sites Stand-alone
  Other conditions: Dyslipidemia With Hypertension
  View official trial listing →
• Terminated NCT NCT03106597

  Manidipine Versus Amlodipine in Patients With Hypertension

  Not yet reported Korea University Guro Hospital 46 participants Est. completion 2019-08-14 3 sites
  Other conditions: Hypertension
  View official trial listing →
• Status unknown NCT NCT03147092

  Matão Controlling Hypertension (MatCH Study): Rationale and Design

  Not yet reported Centro Neurológico de Pesquisa e Reabiitação, Brazil 15000 participants Est. completion 2021-06-30 Stand-alone
  Other conditions: Hypertension, Blood Pressure
  View official trial listing →
• Completed NCT NCT03156842

  Combination of Fimasartan/Amlodipine/Rosuvastatin in Patients With Essential Hypertension and Dyslipidemia

  Not yet reported Boryung Pharmaceutical Co., Ltd 138 participants Est. completion 2018-12-07 1 site Stand-alone
  Other conditions: Essential Hypertension, Dyslipidemia
  View official trial listing →
• Status unknown NCT NCT03195023

  Effect of RAS Blockers on CKD Progression in Elderly Patients With Non Proteinuric Nephropathies (PROERCAN01)

  Not yet reported Hospital General Universitario Gregorio Marañon 106 participants Est. completion 2022-12 1 site
  Other conditions: Renal Insufficiency, Chronic, Proteinuria
  View official trial listing →
• Status unknown NCT NCT03231982

  Study to Confirm the Efficacy and Safety of Fixed-dose Combinations of Amlodipine and Candesartan

  Not yet reported HK inno.N Corporation 210 participants Est. completion 2019-05-31 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT03247140

  The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Male Volunteers Volunteers

  Not yet reported Jeil Pharmaceutical Co., Ltd. 40 participants Est. completion 2017-11-27 1 site Stand-alone
  Other conditions: Hypertension With Dyslipidemia
  View official trial listing →
• Completed NCT NCT03255551

  Blood Pressure Lowering Effects of Amosartan Regarding Proviso iN Patients With High Blood Pressure

  Seoul National University Bundang Hospital 50 participants Est. completion 2015-12-31
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT03276598

  A Study on Molecular Genetics of Drug Responsiveness in Essential Hypertension

  Not yet reported Helsinki University Central Hospital 233 participants Est. completion 2004-04-01 1 site
  Other conditions: Hypertension, Pharmacogenetics
  View official trial listing →
• Status unknown NCT NCT03294070

  Fimasartan Plus Amlodipine on Hemodynamic Parameters and Arterial Stiffness in Patients With Hypertension

  Not yet reported Centro Universitario de Ciencias de la Salud, Mexico 53 participants Est. completion 2018-08 Stand-alone
  Other conditions: Arterial Hypertension
  View official trial listing →
• Withdrawn NCT NCT03319823

  Treating Nocturnal Hypertension and Nocturia in African American Men

  Not yet reported Cedars-Sinai Medical Center Est. completion 2021-02-01 1 site Stand-alone
  Other conditions: High Blood Pressure
  View official trial listing →
• Completed NCT NCT03354143

  Hypertension, Intracranial Pulsatility and Brain Amyloid-beta Accumulation in Older Adults (HIPAC Trial)

  Not yet reported University of Texas Southwestern Medical Center 85 participants Est. completion 2024-03-30 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT03461081

  Drug-drug Interaction Following Oral Administration of Telmisartan/Amlodipine and Atorvastatin in Healthy Adult Volunteers

  Not yet reported Jeil Pharmaceutical Co., Ltd. 32 participants Est. completion 2017-12-12 1 site Stand-alone
  Other conditions: Hypertension With Hyperlipidemia
  View official trial listing →
• Status unknown NCT NCT03489317

  Gut Microbiomes in Patients With Metabolic Syndrome

  Chinese University of Hong Kong 1000 participants Est. completion 2021-12 2 sites
  Metabolic syndrome
  View official trial listing →
• Completed NCT NCT03504735

  Caduet and TLC Intervention in Metabolic Syndrome

  Not yet reported The University of Texas Medical Branch, Galveston 53 participants Est. completion 2016-02-28
  Metabolic syndrome
  View official trial listing →
• Completed NCT NCT03515772

  Drug-drug Interactions Between Antiretroviral Drugs and Cardiovascular Drugs in Elderly Patients

  Centre Hospitalier Universitaire Vaudois 21 participants Est. completion 2019-08-29 2 sites
  Cardiovascular disease Other conditions: HIV Infections, Drug Interactions
  View official trial listing →
• Completed NCT NCT03536598

  Study to Evaluate the Safety and Efficacy of CJ-30060 in Hypertensive Patients With Hyperlipidemia

  Not yet reported HK inno.N Corporation 203 participants Est. completion 2017-09-04 Stand-alone
  Other conditions: Hypertension With Hyperlipidemia
  View official trial listing →
• Completed NCT NCT03553810

  Role of ARNi in Ventricular Remodeling in Hypertensive LVH

  Not yet reported National Heart Centre Singapore 80 participants Est. completion 2024-06-28 1 site Stand-alone
  Other conditions: Hypertensive Heart Disease
  View official trial listing →
• Completed NCT NCT03566316

  Efficacy/Safety of Telmisartan/Amlodipine/Rosuvastatin in Hypertensive Patients With Hyperlipidemia

  Not yet reported IlDong Pharmaceutical Co Ltd 134 participants Est. completion 2017-06-16 1 site Stand-alone
  Other conditions: Hypertension With Hyperlipidemia
  View official trial listing →
• Status unknown NCT NCT03626259

  Losartan/Amlodipine on Hemodynamics Parameters and Arterial Stiffness in Arterial Hypertension

  Not yet reported Centro Universitario de Ciencias de la Salud, Mexico 28 participants Est. completion 2019-06-14 1 site
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT03635125

  Efficacy and Safety of Nebivolol Versus Metoprolol in Hypertensive Subject Taking Amlodipine

  Not yet reported Trinity Hypertension & Metabolic Research Institute 40 participants Est. completion 2011-07-18 1 site
  Other conditions: JNC 7 Stage 1 or 2 Hypertension
  View official trial listing →
• Completed NCT NCT03639493

  Bioequivalence Study of CJ-30060 in Healthy Male Volunteers

  Not yet reported HK inno.N Corporation 52 participants Est. completion 2018-05-17 1 site Stand-alone
  Other conditions: Healthy Male Subjects
  View official trial listing →
• Completed NCT NCT03640312

  Efficacy and Safety of a Quadruple Ultra-low-dose Treatment for Hypertension

  Not yet reported Washington University School of Medicine 62 participants Est. completion 2024-07-31 2 sites Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT03648333

  Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects (N=27)

  Not yet reported Hanlim Pharm. Co., Ltd. 27 participants Est. completion 2014-06 Stand-alone
  Other conditions: Healthy Male Subjects
  View official trial listing →
• Completed NCT NCT03657472

  Bioequivalence Study of CJ-30061 in Healthy Male Volunteers

  Not yet reported HK inno.N Corporation 42 participants Est. completion 2016-11-09 1 site Stand-alone
  Other conditions: Hypertension, Hyperlipidemia
  View official trial listing →
• Completed NCT NCT03657550

  Bioavailability of 5 mg of Levamlodipine Maleate Tablets Versus 10 mg of Amlodipine Besylate Tablet in Healthy Subjects

  Not yet reported Conjupro Biotherapeutics, Inc. 36 participants Est. completion 2018-09-06 1 site
  Other conditions: Hypertension
  View official trial listing →
• Status unknown NCT NCT03660397

  Adrenal Artery Ablation for Uncontrolled Hypertension

  Not yet reported Third Military Medical University 40 participants Est. completion 2020-01-01 1 site Stand-alone
  Other conditions: Uncontrolled Hypertension
  View official trial listing →
• Completed NCT NCT03662620

  Clinical Trial to Compare the Safety and Pharmacokinetics of YH22162 in Healthy Volunteers

  Not yet reported Yuhan Corporation 67 participants Est. completion 2018-12-22 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT03666351

  Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disease

  Not yet reported Hanmi Pharmaceutical Company Limited 128 participants Est. completion 2022-07-25 1 site Stand-alone
  Other conditions: Aortic Stenosis, Aortic Regurgitation, Hypertension, LVM, Left Ventricular Hypertrophy
  View official trial listing →
• Status unknown NCT NCT03667677

  Comparison of Tandospirone, Amlodipine and Their Combination in Adults With Hypertension and Anxiety

  Not yet reported Chongqing Medical University 256 participants Est. completion 2020-07-01 7 sites Stand-alone
  Other conditions: Hypertension, Anxiety
  View official trial listing →
• Completed NCT NCT03683069

  Mineralocorticoid Receptor (MR) Antagonist (Eplerenone) vs Amlodipine and STRIATIN

  Not yet reported Brigham and Women's Hospital 90 participants Est. completion 2024-01-31 1 site Stand-alone
  Other conditions: Hypertension, Genetics Hypertension
  View official trial listing →
• Completed NCT NCT03747978

  Short-term Effects of Perindopril-amlodipine Versus Perindopril-indapamide in Type 2 Diabetes

  Not yet reported Yaounde Central Hospital 30 participants Est. completion 2017-05-30 1 site Stand-alone
  Type 2 diabetes Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT03753477

  Clinical Trial to Investigate the Efficacy and Safety of DWJ1351

  Not yet reported Daewoong Pharmaceutical Co. LTD. 64 participants Est. completion 2018-02-01 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Terminated NCT NCT03783754

  Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial Magnetic Resonance Imaging Sub-study

  Not yet reported The George Institute 4 participants Est. completion 2021-03-21 3 sites Stand-alone
  Cardiovascular disease Other conditions: Cerebral Small Vessel Diseases, Intracerebral Hemorrhage, Vascular Dementia, Hypertension
  View official trial listing →
• Terminated NCT NCT03785067

  Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT) Cognitive Sub-Study

  Not yet reported The George Institute 1 participants Est. completion 2021-02-03 4 sites Stand-alone
  Cardiovascular disease Other conditions: Cognitive Decline, Intracerebral Hemorrhage, Dementia, Vascular, Cerebral Small Vessel Diseases, Hypertension
  View official trial listing →
• Completed NCT NCT03889145

  A Study to Evaluate the Drug-drug Interaction Between Telmisartan, Amlodipine and Hydrochlorothiazide

  Not yet reported IlDong Pharmaceutical Co Ltd 30 participants Est. completion 2014-02-19 Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT03912285

  The Pharmacokinetic Interaction Between Amlodipine and Losartan

  Not yet reported Korea University Anam Hospital 24 participants Est. completion 2009-06-09 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Active, not recruiting NCT NCT03938389

  The Renin-Angiotensin-Aldosterone System in Adiposity, Blood Pressure and Glucose in African Americans

  Not yet reported Ohio State University 90 participants Est. completion 2026-06 1 site
  Prediabetes Other conditions: Obesity, Blood Pressure
  View official trial listing →
• Completed NCT NCT03946514

  Efficacy and Safety of a Single-pill Fixed Combination of Sufficient Losartan/Hydrochlorothiazide in Chinese Hypertensive Patients

  Not yet reported Shanghai Jiao Tong University School of Medicine 180 participants Est. completion 2024-08-31 1 site
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT03951207

  Rosuvastatin/Amlodipine vs Atorvastatin/Amlodipine in Hypertension Patient With Dyslipidemia

  Not yet reported Yuhan Corporation 259 participants Est. completion 2021-09-29 1 site Stand-alone
  Other conditions: Dyslipidemias, Hypertension
  View official trial listing →
• Status unknown NCT NCT03956823

  Clinical Efficacy of Telmisartan in Reducing Cardiac Remodeling Among Obese Patients With Hypertension

  Not yet reported First Affiliated Hospital Xi'an Jiaotong University 300 participants Est. completion 2021-12-01 1 site
  Other conditions: Hypertension
  View official trial listing →
• Withdrawn NCT NCT03978884

  Phase 4 Study of the Efficacy of Losartan Based Therapy in Hypertensives With and Without Diabetes

  Not yet reported The University of The West Indies Est. completion 2020-12-31 1 site Stand-alone
  Other conditions: Diabetes Mellitus, Hypertension
  View official trial listing →
• Completed NCT NCT03990480

  Valsartan Versus Amlodipine Effect on Left Ventricular Multidirectional Deformation and Adipocytokines Level

  Not yet reported Damanhour University 230 participants Est. completion 2019-04-10 1 site
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT03991442

  BR1010 in Patients With Essential Hypertension Patients Who do Not Adequately Respond to Fimasartan/Amlodipine Combination

  Not yet reported Boryung Pharmaceutical Co., Ltd 257 participants Est. completion 2021-03-02 1 site Stand-alone
  Other conditions: Essential Hypertension
  View official trial listing →
• Completed NCT NCT04036409

  Optimal Blood Pressure for the prevenTIon of Major vAscuLar Events in Stroke Patients

  Not yet reported Hospital Israelita Albert Einstein 4368 participants Est. completion 2026-07-08 30 sites Stand-alone
  Cardiovascular disease Other conditions: Blood Pressure, Cognitive Impairment, Vascular Diseases
  View official trial listing →
• Completed NCT NCT04040634

  Optimal Blood Pressure for the prevenTIon of Major vAscuLar Events in Patients With DIABETES Mellitus (OPTIMAL-DIABETES)

  Not yet reported Hospital Israelita Albert Einstein 9476 participants Est. completion 2026-07-08 32 sites Stand-alone
  Cardiovascular disease Other conditions: Diabetes Mellitus, High Blood Pressure, Cognitive Impairment
  View official trial listing →
• Completed NCT NCT04074551

  A Phase 3 Study to Compare the Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and Dyslipidemia

  Not yet reported Hanmi Pharmaceutical Company Limited 145 participants Est. completion 2020-03-17 1 site
  Other conditions: Hypertension, Dyslipidemias
  View official trial listing →
• Completed NCT NCT04081844

  A Study to Evaluate the Pharmacokinetic and Pharmacodynamic Interactions Between HGP0904, HGP0608, and HCP1306 in Healthy Male Subjects.

  Not yet reported Hanmi Pharmaceutical Company Limited 31 participants Est. completion 2018-06-28 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT04085562

  Effect of Amlodipine Versus Bisoprolol on Hypertensive Patients With End-stage Renal Disease on Maintenance Hemodialysis.

  Not yet reported Alexandria University 46 participants Est. completion 2021-02-01 1 site Stand-alone
  Other conditions: Hypertension, Renal
  View official trial listing →
• Active, not recruiting NCT NCT04111419

  Intensive Management of Blood Pressure and Cholesterol in Elderly Chinese With Hypertension and Atrial Fibrillation

  Not yet reported Shanghai Jiao Tong University School of Medicine 1200 participants Est. completion 2026-12-31 1 site Stand-alone
  Other conditions: Atrial Fibrillation, Hypertension
  View official trial listing →
• Withdrawn NCT NCT04121299

  Mechanism of Masked Hypertension - Intervention

  Not yet reported University of Alabama at Birmingham Est. completion 2026-06 1 site
  Other conditions: Masked Hypertension
  View official trial listing →
• Completed NCT NCT04158076

  Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan/Amlodipine

  Not yet reported Addpharma Inc. 131 participants Est. completion 2021-01-14 1 site Stand-alone
  Other conditions: Hypercholesterolemia, Hypertension
  View official trial listing →
• Completed NCT NCT04158154

  Transforming Hypertension Treatment in Nigeria Using a Type II Hybrid, Interrupted Time Series Design

  Not yet reported Washington University School of Medicine 21922 participants Est. completion 2023-12-31 60 sites Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Status unknown NCT NCT04161001

  Clinical Trail to Evaluate the Efficacy and Safety of DWJ1451

  Not yet reported Daewoong Pharmaceutical Co. LTD. 237 participants Est. completion 2022-02-02 1 site Stand-alone
  Other conditions: Hypertension, Dyslipidemia
  View official trial listing →
• Completed NCT NCT04179019

  Calcium Channel Blockade in Primary Aldosteronism

  Not yet reported Brigham and Women's Hospital 15 participants Est. completion 2023-12-30 1 site Stand-alone
  Other conditions: Primary Aldosteronism, Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)
  View official trial listing →
• Status unknown NCT NCT04185090

  To Evaluate the Pharmacokinetic/Pharmacodynamic Interactions and Safety Between ID1801 and ID1803 in Healthy Male Adults

  Not yet reported IlDong Pharmaceutical Co Ltd 30 participants Est. completion 2020-04 Stand-alone
  Other conditions: Hypertension, Dyslipidemias
  View official trial listing →
• Completed NCT NCT04218552

  Determining the Optimal Dose of AD-209 in Patients With Essential Hypertension

  Not yet reported Addpharma Inc. 176 participants Est. completion 2021-02-25 1 site
  Other conditions: Hypertension,Essential
  View official trial listing →
• Status unknown NCT NCT04306627

  Effect of Atorvastatin on Carotid Intima Media Thickness

  Not yet reported Yerevan State Medical University 200 participants Est. completion 2021-02-28
  Other conditions: Essential Hypertension, Hypercholesterolemia
  View official trial listing →
• Terminated NCT NCT04329806

  Sympathetic Mechanisms in the Cardiovascular and Metabolic Alterations of Obesity

  Not yet reported Italo Biaggioni 10 participants Est. completion 2022-07-27 1 site
  Other conditions: Obesity-Associated Insulin Resistance
  View official trial listing →
• Suspended NCT NCT04330300

  Coronavirus (COVID-19) ACEi/ARB Investigation

  Not yet reported National University of Ireland, Galway, Ireland 2414 participants Est. completion 2021-12-01 1 site
  Other conditions: Hypertension, COVID-19
  View official trial listing →
• Completed NCT NCT04364139

  African American Study of Kidney Disease and Hypertension

  Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 1094 participants Est. completion 2007-06-30 Stand-alone
  Other conditions: Hypertensive Nephrosclerosis, Chronic Renal Insufficiency
  View official trial listing →
• Status unknown NCT NCT04455178

  The Comparison Between Spironolactone and Indapamide Monotherapy or in Combination With Amlodipine to Reduce the Risk of Heart Failure

  Not yet reported Shanghai Jiao Tong University School of Medicine 200 participants Est. completion 2023-12-31 4 sites
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT04467931

  ACEI or ARB and COVID-19 Severity and Mortality in US Veterans

  University of Utah 22213 participants Est. completion 2020-12-31 1 site
  Other conditions: Hypertension, COVID
  View official trial listing →
• Status unknown NCT NCT04554303

  Comparing Safety and Efficacy of Amlodipine Verses S Amlodipine in Patients With Essential Hypertension

  Ahn-Gook Pharmaceuticals Co.,Ltd 80 participants Est. completion 2022-05-23 1 site
  Other conditions: Essential Hypertension
  View official trial listing →
• Completed NCT NCT04559074

  Personalised Electronic Record Supported Optimisation When Alone for Patients With Hypertension

  Not yet reported Queen Mary University of London 343 participants Est. completion 2021-11-19 2 sites Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT04667624

  Study to Evaluate the Safety and PK of LODIENT Tablet 80/2.5mg in Healthy Adult Volunteers

  Not yet reported Hanlim Pharm. Co., Ltd. 32 participants Est. completion 2020-05-18 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Status unknown NCT NCT04686643

  Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension

  Not yet reported Ahn-Gook Pharmaceuticals Co.,Ltd 306 participants Est. completion 2022-05-01 Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Active, not recruiting NCT NCT04840342

  MR Antagonist and LSD1

  Not yet reported Brigham and Women's Hospital 300 participants Est. completion 2026-06 1 site Stand-alone
  Other conditions: Hypertension, Mineralocorticoid Excess
  View official trial listing →
• Status unknown NCT NCT04929600

  Sacubitril/Valsartan Versus Amlodipine in Hypertension and Left Ventricular Hypertrophy.

  Not yet reported Shanghai Jiao Tong University School of Medicine 120 participants Est. completion 2023-12 1 site Stand-alone
  Other conditions: Hypertension, Left Ventricular Hypertrophy
  View official trial listing →
• Completed NCT NCT04952051

  Enalapril Folic Acid Tablets Combined With CCB or Diuretic to Prevent Stroke in Patients With Type H Hypertension

  Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 1000 participants Est. completion 2020-07-01 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Withdrawn NCT NCT04954196

  Benefit of Amlodipine in HRT Cycle for Frozen Embryo Transfer in the Correction of Uterine Pulsatility Index

  Not yet reported University Hospital, Montpellier Est. completion 2024-09-08 Stand-alone
  Other conditions: Frozen Embryo Transfer
  View official trial listing →
• Status unknown NCT NCT04962841

  Nutraceuticals and Drug Treatment in Frail Older Adults

  University of Campania Luigi Vanvitelli 485 participants Est. completion 2023-04-01 1 site
  Other conditions: Frailty
  View official trial listing →
• Withdrawn NCT NCT04978649

  Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes-----renal Substudy

  Not yet reported Guangdong Provincial People's Hospital Est. completion 2028-07-31
  Type 2 diabetes Other conditions: Blood Pressure
  View official trial listing →
• Status unknown NCT NCT05077462

  A Clinical Trial to Evaluate the Safety and Pharmacokinetics of AJU-C52H in Healthy Volunteers

  Not yet reported AJU Pharm Co., Ltd. 60 participants Est. completion 2022-04-30 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Status unknown NCT NCT05077475

  A Clinical Trial to Evaluate the Safety and Pharmacokinetics of AJU-C52L in Healthy Volunteers

  Not yet reported AJU Pharm Co., Ltd. 60 participants Est. completion 2022-04-30 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT05103332

  Zilebesiran as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive Medication (KARDIA-2)

  Not yet reported Alnylam Pharmaceuticals 663 participants Est. completion 2024-09-13 110 sites Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT05155436

  Occurrence of Dyskalemia With Treatment for Hypertension

  Not yet reported National Heart Foundation of Bangladesh 1090 participants Est. completion 2023-03-31 1 site Stand-alone
  Other conditions: Hypertension, Potassium Imbalance
  View official trial listing →
• Status unknown NCT NCT05165251

  Blood Pressure and Lipids Reduction in High Risk Elderly Patients With Isolated Systolic Hypertension

  Not yet reported Shanghai Jiao Tong University School of Medicine 480 participants Est. completion 2025-06-01 1 site Stand-alone
  Other conditions: Isolated Systolic Hypertension
  View official trial listing →
• Not yet recruiting NCT NCT05169021

  Folic Acid and Intensive Antihypertensive Therapy for Hypertension With CSVD

  Not yet reported Beijing Tiantan Hospital 15000 participants Est. completion 2028-12-31 1 site
  Cardiovascular disease Other conditions: Cerebral Small Vessel Diseases
  View official trial listing →
• Status unknown NCT NCT05173025

  Effect of Fimasartan on Extended RAS and Vascular Functions in Patients With Type 2 Diabetes and Hypertension

  Not yet reported Seoul National University Bundang Hospital 42 participants Est. completion 2023-12-31 1 site
  Type 2 diabetes Other conditions: Hypertension, Atherosclerosis, Renin Hypertension
  View official trial listing →
• Withdrawn NCT NCT05275907

  Mechanism of Hypertension Treatments in Liver Transplant Recipients (BLOCK LTR-HTN)

  Not yet reported Northwestern University Est. completion 2023-10-04 1 site
  Other conditions: High Blood Pressure, Liver Transplant, Renal Function Abnormal
  View official trial listing →
• Completed NCT NCT05279807

  Effectiveness and Safety of Combination of Amlodipine and Zofenopril in Hypertensive Patients Versus Each Monotherapy

  Not yet reported Menarini International Operations Luxembourg SA 277 participants Est. completion 2022-04-28 1 site
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT05288400

  Evaluation of the Clinical Efficacy and Safety of Amlodipine 5mg/ Bisoprolol Fumarate 5mg /Perindopril Arginine 5mg Fixed-dose Combination in Capsule and Free Monotherapy at the Same Dose in Patients With Uncontrolled Essential Hypertension.

  Not yet reported Servier 150 participants Est. completion 2018-12-18 15 sites Stand-alone
  Other conditions: Essential Hypertension
  View official trial listing →
• Active, not recruiting NCT NCT05331144

  Impact of Intensive Treatment of SBP on Brain Perfusion, Amyloid, and Tau (IPAT Study)

  Not yet reported Rong Zhang 180 participants Est. completion 2028-08-31 1 site Stand-alone
  Other conditions: Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline, Family History of Dementia
  View official trial listing →
• Terminated NCT NCT05370599

  Hypertension in Young Adults Trial

  Not yet reported University of California, San Francisco 36 participants Est. completion 2026-01-07 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Status unknown NCT NCT05398393

  An Experimental Study on the Effect of Tenofovir Amibufenamide on Blood Lipid During Anti-HBV Treatment

  Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 150 participants Est. completion 2023-06-30 1 site
  Other conditions: Hepatitis B, Chronic, Lipid Disorder
  View official trial listing →
• Completed NCT NCT05462535

  An Observational Study to Evaluate Effectiveness and Safety of Amosartan Plus Tablet

  Hanmi Pharmaceutical Company Limited 4785 participants Est. completion 2021-07-15 1 site
  Other conditions: Hypertension,Essential
  View official trial listing →
• Completed NCT NCT05470764

  Bioequivalence Study of 8 mg Perindopril Tert-Butylamine / 2.5 mg Indapamide / 10 mg Amlodipine Tablets Versus 10 mg Perindopril Arginine / 2.5 mg Indapamide / 10 mg Amlodipine Film-Coated Tablets in Healthy Volunteers

  Not yet reported Darnitsa Pharmaceutical Company 52 participants Est. completion 2021-06-28 1 site Stand-alone
  Other conditions: Bioequivalence, Healthy Subjects
  View official trial listing →
• Completed NCT NCT05475665

  Clinical Efficacy and Safety Evaluation of Irbesartan High and Amlodipine Combined Therapy in Essential Hypertension Patients

  Not yet reported Handok Inc. 157 participants Est. completion 2023-06-13 1 site Stand-alone
  Other conditions: Essential Hypertension
  View official trial listing →
• Completed NCT NCT05479097

  Feasibility Study of a Novel mHealth Application to Enable Community Health Workers to Manage

  Not yet reported University of Wisconsin, Madison 32 participants Est. completion 2023-12-31 1 site
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT05513937

  Effectiveness and Safety of Combination of Nebivolol and Amlodipine in Hypertensive Patients Versus Each Monotherapy

  Not yet reported Menarini International Operations Luxembourg SA 301 participants Est. completion 2022-11-15 1 site
  Other conditions: Hypertension
  View official trial listing →
• Status unknown NCT NCT05545059

  Effects and Safety of Sacubitril/Valsartan on Refractory Hypertension

  Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 138 participants Est. completion 2023-03-31 1 site Stand-alone
  Other conditions: Resistant Hypertension
  View official trial listing →
• Active, not recruiting NCT NCT05660135

  Reduction Efficacy of OLOMAX for Blood Pressure and Low-density Lipoprotein Cholesterol in Hypertensive Patients With Dyslipidemia

  Daewoong Pharmaceutical Co. LTD. 4000 participants Est. completion 2025-12-31 1 site
  Other conditions: Hypertension, Dyslipidemias
  View official trial listing →
• Status unknown NCT NCT05667818

  An Comparative Pharmacokinetic Study of Amlodipine Besylate Controlled-release Tablets,China in Normal, Healthy, Adult, Human Subjects Under Fasting Conditions

  Not yet reported Overseas Pharmaceuticals, Ltd. 16 participants Est. completion 2023-03-10 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT05683301

  Treatment Optimisation for Blood Pressure With Single-Pill Combinations in India

  Not yet reported Centre for Chronic Disease Control, India 1981 participants Est. completion 2024-09-22 35 sites Stand-alone
  Other conditions: Primary Hypertension
  View official trial listing →
• Completed NCT NCT05688098

  Pharmacokinetics of Irbesartan/Amlodipine High FDC and Co-administration of Irbesartan and Amlodipine High in Healthy Volunteers

  Not yet reported Handok Inc. 44 participants Est. completion 2023-04-21 1 site
  Other conditions: Healthy Volunteers
  View official trial listing →
• Completed NCT NCT05764317

  Description of the Effectiveness, Safety, Tolerability and Adherence to Amlodipine/Atorvastatin/Perindopril Single Pill Combination Treatment in Patients With Arterial Hypertension and Dyslipidemia (TARGET)

  Servier Russia 409 participants Est. completion 2024-02-20 1 site
  Other conditions: Arterial Hypertension, HTN
  View official trial listing →
• Status unknown NCT NCT05843162

  A Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive Patients With Metabolic Syndrome

  Not yet reported Chong Kun Dang Pharmaceutical 116 participants Est. completion 2023-12-31 Stand-alone
  Metabolic syndrome Other conditions: Essential Hypertension
  View official trial listing →
• Status unknown NCT NCT05899920

  Clinical One-stage Controlled Study of reSistant Arterial Hypertension for the desiGning of a personAlized Approach to Therapy

  Not yet reported Ryazan State Medical University 190 participants Est. completion 2024-12-31 1 site Stand-alone
  Other conditions: Resistant Arterial Hypertension
  View official trial listing →
• Status unknown NCT NCT05917275

  Multi-Omics to Predict the Blood Pressure Response to Antihypertensives

  Not yet reported Radboud University Medical Center 96 participants Est. completion 2025-10 1 site Stand-alone
  Other conditions: Primary Hypertension
  View official trial listing →
• Completed NCT NCT05920005

  Candesartan Cilexetil + Chlorthalidone + Amlodipine Versus Exforge HCT®️ for Systemic Arterial Hypertension

  Not yet reported Hospital Israelita Albert Einstein 702 participants Est. completion 2025-05-01 22 sites Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Status unknown NCT NCT05940909

  Bioequivalence Study of Perindopril /Amlodipine/Indapamide 8 mg (10 mg)/2.5 mg/10 mg Tablets in Healthy Volunteers Under Fasting Conditions

  Not yet reported Pharmtechnology LLC 50 participants Est. completion 2023-11-17 1 site
  Other conditions: Bioequivalence
  View official trial listing →
• Status unknown NCT NCT05954884

  Community-based HEARTS Intervention (Pilot)

  Not yet reported National Heart Foundation of Bangladesh 400 participants Est. completion 2025-03-31 Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Status unknown NCT NCT05976438

  Skin Sodium and Salt Sensitivity of Blood Pressure

  Not yet reported Cambridge University Hospitals NHS Foundation Trust 60 participants Est. completion 2024-12 2 sites
  Other conditions: Hypertension
  View official trial listing →
• Active, not recruiting NCT NCT06041529

  Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients With Essential Hypertension

  Not yet reported Yuhan Corporation 198 participants Est. completion 2026-02-28 15 sites Stand-alone
  Other conditions: Essential Hypertension
  View official trial listing →
• Status unknown NCT NCT06130124

  S-amlodipine in Essential HypertensIon and Assessment of Blood Pressure Targets Achievement

  Hanlim Pharm. Co., Ltd. 5000 participants Est. completion 2025-07-25 1 site
  Other conditions: Essential Hypertension
  View official trial listing →
• Status unknown NCT NCT06164379

  Efficacy and Safety of Finerenone vs. Spironolactone in Patients With Primary Aldosteronism

  Not yet reported Shanghai Jiao Tong University School of Medicine 150 participants Est. completion 2024-12-16 1 site Stand-alone
  Other conditions: Primary Aldosteronism
  View official trial listing →
• Status unknown NCT NCT06214832

  An Observation Study on the Identification of Prescription Patterns of Lodient Tab(Telmisartan/S-amlodipine)

  Hanlim Pharm. Co., Ltd. 4000 participants Est. completion 2025-08-30 1 site
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT06236061

  Study of Efficacy and Safety of LCZ696/Amlodipine in Grade 1 and 2 Hypertension Patients Uncontrolled by LCZ696 Monotherapy

  Not yet reported Novartis Pharmaceuticals 718 participants Est. completion 2025-12-23 43 sites Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT06259175

  Evaluation of the Antihypertensive effectIveness, Tolerability, and Adherence With Amlodipine/ Indapamide/ Perindopril Triple Single-pill Combination in Hypertensive Patients Without Concomitant Antihypertensive Therapy (TRIPTYCH)

  Servier Russia 396 participants Est. completion 2025-06-01 1 site
  Other conditions: Arterial Hypertension, HTN
  View official trial listing →
• Status unknown NCT NCT06275763

  Optimal Medical Treatment of Difficult-to-treat Hypertension

  Not yet reported National Institute of Cardiology, Warsaw, Poland 2500 participants Est. completion 2025-12-31 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Not yet recruiting NCT NCT06282107

  Effectiveness and Safety of BiSAAE for Resistant Hypertension.

  Not yet reported First Affiliated Hospital of Chengdu Medical College 72 participants Est. completion 2026-12-31 Stand-alone
  Other conditions: Resistant Hypertension
  View official trial listing →
• Completed NCT NCT06293261

  Multicenter, Prospective, Non-interventional, Observational Study to Confirm the Long-term Efficacy and Safety of Rosuampin Tab. in Patients With Hypertension and Hypercholesterolemia

  Yuhan Corporation 5047 participants Est. completion 2024-03-31 39 sites
  Other conditions: Hypertension, Hypercholesterolemia
  View official trial listing →
• Completed NCT NCT06395194

  Effects of Valsartan vs Amlodipine and Low BP on Kidney Outcomes in Essential Hypertension

  Not yet reported Oslo University Hospital 15313 participants Est. completion 2003-12-05
  Other conditions: Essential Hypertension
  View official trial listing →
• Completed NCT NCT06465264

  To Assess Allisartan Isoproxil/Amlodipine in Patients With Essential Hypertension Uncontrolled With Amlodipine or Allisartan Isoproxil

  Not yet reported Shenzhen Salubris Pharmaceuticals Co., Ltd. 499 participants Est. completion 2023-02-24 1 site Stand-alone
  Other conditions: Essential Hypertension
  View official trial listing →
• Completed NCT NCT06487949

  Valsartan and Amlodipine in Blood Pressure Management: Fixed-Dose vs. Free Drug Therapy

  Not yet reported Shiraz University of Medical Sciences 114 participants Est. completion 2023-12-01 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Status unknown NCT NCT06515678

  Impact of Antihypertensive Therapy on Recurrence Risk of Ovarian Cancer for Bevacizumab-associated Hypertension

  Groupe Hospitalier Pitie-Salpetriere 9464 participants Est. completion 2024-08-31 2 sites
  Other conditions: Ovarian Cancer, Antiangiogenic-Associated Hypertension, Adjuvant Bevacizumab, Hypertension
  View official trial listing →
• Active, not recruiting NCT NCT06618079

  Drug-Drug Interaction Study Between HUC2-565-A and HUC2-565-B

  Not yet reported Huons Co., Ltd. 46 participants Est. completion 2024-10-01 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Enrolling by invitation NCT NCT06646354

  To Evaluate the Efficacy and Safety of Co-administrated HODO-2224-1 and HODO-2224-2 in Patients With Essential Hypertension and Primary Hypercholesterolemia

  Not yet reported Hyundai Pharm 125 participants Est. completion 2028-12-31 1 site Stand-alone
  Other conditions: Hypertension, Primary Hypercholesterolaemia
  View official trial listing →
• Completed NCT NCT06704815

  Observational Cohort Study Evaluating the Effectiveness of an Educational Program (NGAYDAUTIEN) in Combination With Perindopril and Amlodipine Single-Pill Combination in Hypertensive Patients naïve of Antihypertensive Treatments.

  Servier Affaires Médicales 400 participants Est. completion 2024-06-12 1 site
  Other conditions: Hypertension
  View official trial listing →
• Withdrawn NCT NCT06713785

  Personalised Electronic Record Supported Optimisation of Amlodipine for Patients With Hypertension

  Not yet reported Queen Mary University of London Est. completion 2021-05-31
  Other conditions: Hypertension
  View official trial listing →
• Withdrawn NCT NCT06730945

  Effect of Oral Isosorbide Mononitrate Plus Amlodipine Antispasm Therapy on Outcomes of Radial Artery Grafts After CABG

  Not yet reported Ruijin Hospital Est. completion 2030-12 1 site Stand-alone
  Other conditions: Coronary Artery Bypass Graft Surgery (CABG), Radial Artery Grafts, Graft Failure
  View official trial listing →
• Not yet recruiting NCT NCT06771245

  A Phase III Clinical Trial Evaluating the Efficacy and Safety of Valsartan/Levamlodipine (SYH9056) Tablets In Hypertensive Patients

  Not yet reported CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 606 participants Est. completion 2026-10-30
  Other conditions: Mild-to-moderate Essential Hypertension
  View official trial listing →
• Not yet recruiting NCT NCT06780865

  Protecting Renal Function in Chronic Kidney Disease Patients with Isolated Nighttime Hypertension

  Not yet reported Shanghai Institute of Hypertension 200 participants Est. completion 2028-12-31 Stand-alone
  Chronic kidney disease Other conditions: Nocturnal Hypertension
  View official trial listing →
• Not yet recruiting NCT NCT06790927

  Standardized Antihypertensive Treatment Protocol

  Not yet reported Shanghai Jiao Tong University School of Medicine 400 participants Est. completion 2026-12-31 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Not yet recruiting NCT NCT06942377

  Calcium Channel Blocker Amlodipine for Endometrial Cancer Therapy

  Not yet reported Peking University People's Hospital 140 participants Est. completion 2027-12-01 1 site Stand-alone
  Other conditions: Endometrial Cancer
  View official trial listing →
• Enrolling by invitation NCT NCT07064525

  Evaluate the Efficacy and Safety of SPC1001 Low in Patients With Essential Hypertension

  Not yet reported Shin Poong Pharmaceutical Co. Ltd. 252 participants Est. completion 2026-02-28 1 site
  Heart failure Other conditions: Hypertension (HTN), Diabete Mellitus
  View official trial listing →
• Not yet recruiting NCT NCT07075965

  Calcium Channel Blocker in Myotonic Dystrophy Type 1

  Not yet reported University of Rochester 20 participants Est. completion 2030-10-01 Stand-alone
  Other conditions: Myotonic Dystrophy 1
  View official trial listing →
• Completed NCT NCT07116863

  A Multicenter, Randomized, Double-Blind Phase 3 Trial of KDF1901 in Patients With Essential Hypertension

  Not yet reported Kyungdong Pharmaceutical Co., Ltd. 286 participants Est. completion 2024-09-13 2 sites Stand-alone
  Other conditions: Essential Hypertension
  View official trial listing →
• Not yet recruiting NCT NCT07241338

  Sacubitril/Allisartan for Hypertensive Patients With Overweight or Obesity

  Not yet reported Jing Liu 104 participants Est. completion 2027-06 1 site
  Other conditions: Hypertension
  View official trial listing →
• Not yet recruiting NCT NCT07262710

  Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort Study

  First Teaching Hospital of Tianjin University of Traditional Chinese Medicine 13656 participants Est. completion 2026-08-19
  Cardiovascular disease
  View official trial listing →
• Not yet recruiting NCT NCT07291375

  Role of Amlodipine in Reduction of CIN

  Not yet reported Minia University 40 participants Est. completion 2026-07-01
  Other conditions: Contrast-induced Nephropathy
  View official trial listing →
• Completed NCT NCT07327749

  Comparing Bisoprolol and Valsartan-Amlodipine for Hypertension

  Not yet reported Shiraz University of Medical Sciences 59 participants Est. completion 2025-12-12 1 site
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT07436104

  Mortality Control Program for Economically Productive Age Group in Tribal Area of Melghat.

  Not yet reported MAHAN Trust 72564 participants Est. completion 2023-08-31 1 site Stand-alone
  Other conditions: Hypertension (HTN), Diarrhea, Pneumonia, Malaria Fever, COPD, Asthma (Diagnosis), Diarrhea Chronic
  View official trial listing →
• Not yet recruiting NCT NCT07486453

  Bioequivalence Study of Sacubitril Alisartan Amlodipine Tablets

  Not yet reported Shenzhen Salubris Pharmaceuticals Co., Ltd. 60 participants Est. completion 2026-04-25 1 site Stand-alone
  Other conditions: Primary Hypertension
  View official trial listing →
• Completed NCT NCT07564726

  Efficacy and Safety of Ezetimibe/Rosuvastatin and Amlodipine Patients With High Blood Pressure and High Cholesterol

  Not yet reported Celltrion Pharm, Inc. 163 participants Est. completion 2024-02-13 21 sites Stand-alone
  Other conditions: Hypertension, Hypercholesterolemia
  View official trial listing →
• Not yet recruiting NCT NCT07618806

  A Clinical Study Comparing Ankle Swelling Caused by Two Different Blood Pressure Medications, Levamlodipine and Amlodipine, in Post-menopausal Women With Mild High Blood Pressure.

  Not yet reported Zentiva, k.s. 344 participants Est. completion 2028-05-31 Stand-alone
  Other conditions: Hypertension, Oedema
  View official trial listing →

Not yet reported.

Not yet reported.

• ClinicalTrials.gov — NCT03264352

Also known as: Amlodipine Besylate, Amlodipine and Benazepril Hydrochloride, Amlodipine and Olmesartan Medoxomil, Amlodipine, Amlodipine 5mg, Qiaohean

No related coverage yet.